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Organization, separation, and cellular regulation are all functions of 
membraneless organelles (MLOs), which arise by a biophysical phenomenon termed 
liquid-liquid phase separation (LLPS). By this process, macromolecules in a mixed liquid 
solution condense together to form liquid droplets within a liquid solution, comparable to 
oil droplets in water. Some known MLOs formed in cells via LLPS include nucleoli, 
stress granules, Cajal bodies, and processing-bodies, among other membrane-lacking 
liquid granules. Previous work has shown that many proteins which compose these 
liquid compartments also undergo LLPS isolated in vitro, and thus have become model 
systems to investigate the forces that drive these macromolecules to undergo phase 
transitions.  
 Currently, the LLPS field has identified key features of proteins which contribute 
to phase separation. Included in this are sequences of intrinsic disorder and structured 
sequences, prion-like regions, oligomerization, and multivalent interactions. In this 
thesis, the protein of interest, UBQLN2, contains all such features. Additionally, prior 
work in the Castañeda lab and others has shown that UBQLN2 is recruited to stress 
granules, and disease-related inclusion bodies. In vitro, UBQLN2 phase separates into 
spherical liquid droplets in a concentration and temperature-dependent manner. As 
UBQLN2 exhibits LLPS both in vitro and in vivo, it serves as a model system to 
uncover, on a molecular level, the driving forces of phase separation.  
 The studies provided herein, investigate the properties of UBQLN2 phase 
separation and how they are modified with the introduction of mutations and domain 





can identify a molecular code which UBQLN2 follows to drive and modulate its LLPS. 
Through experimental investigation via turbidity assays, phase diagram construction, 
microscopy, and self-association studies, we elucidate the molecular foundations of 
UBQLN2 LLPS. 
 Here, I propose that UBQLN2 LLPS is driven by “sticker” sequences which 
contribute to interchain interactions, and that hydrophobic and polar interactions are 
important sequence-intrinsic features which drive LLPS and control material properties 
of UBQLN2 droplets. Additionally, I look at UBQLN2 on a domain-by-domain level to 
uncover how sequence features like structure, disorder, and prion propensity may 
contribute differently to phase separation. Finally, I propose a method of UBQLN2 
purification that potentially incorporates native post-translational modifications (PTMs) to 
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Membraneless organelles form via liquid-liquid phase separation 
Cellular organization is a key factor of normal cell function. Classically, the idea 
of membrane-bound organelles and compartments form the foundation of cellular 
organization. However, scientists have recently discovered the importance of 
membraneless organelles (MLOs), though the presence of MLOs has been recognized 
for nearly two centuries (Wilson, 1899). Membraneless organelles (MLOs) introduce a 
novel paradigm of cellular organization. MLOs add compartmentalization of cellular 
components through separation of cellular material, without a discrete external barrier 
like a lipid bilayer. Unlike their membrane-bound counterparts, these organelles are 
dynamic, allow constituents to easily enter and exit, and are thought to be regulated by 
various factors like cellular stressors, post-translational modifications (PTMs), or post-
transcriptional RNA modifications (Drino and Schaefer, 2018; Saito et al., 2019; 
Shapouri et al., 2016). Different MLOs hold distinct physiological functions which impact 
stress response, development, and regulation of gene expression (Drino and Schaefer, 
2018). Given different functions, MLOs must recruit different members, and thus can 
include proteins, mRNA, and DNA (Alberti and Carra, 2018). Largely, these MLOs 
function to allow sub-compartmentalization of biochemical reactions and biological 
processes (Nott et al., 2015). 
MLOs exist as liquid droplets within the cell and arise from condensation of 
cellular material (Gomes and Shorter). Observations have described these organelles 
as having liquid-like material properties such as fusion, dripping, and wetting, with 
molecules continuously entering and exiting (Alberti and Carra, 2018; Brangwynne, 





cellular environment due to their ability to sequester macromolecules and to 
spatiotemporally compartmentalize specific biochemical reactions, while also allowing 
diffusion of biomolecules into and out of the organelle. Nucleoli, Cajal bodies, P-bodies, 
and stress granules are all examples of MLOs in cells, and their function is largely 
contingent on the macromolecules they contain (Figure 1A). Functioning as more than 
just an organizational compartment, Cajal bodies, for example, can also tune 
biochemical reactions such as the assembly of U4/U6.U5 tri-snRNP, a spliceosomal 
complex (Novotnýa et al., 2011). Cajal bodies are able to accelerate this reaction and 
others, due to the high concentration of reactants sequestered inside the MLO. 
Processing bodies (P-bodies) play fundamental roles in mRNA degradation, storing, 
and repression, and thus contain many types of mRNAs and enzymes required for 
mRNA degradation (Kulkarni et al., 2010). Stress granules are MLOs which are thought 
to improve fitness during stressed conditions by stalling translation initiation, and by 
regulating signaling events (Alberti and Carra, 2018; Gomes and Shorter; Lin et al., 
2015). Stress granules contain an array of translation initiation factors, RNA binding 
proteins (RBPs), protein quality control regulators, and many other non-RBP proteins 
(Protter and Parker, 2016). Thus, MLOs add an important aspect of cellular organization 
and function in many systems and processes.  
Though common in the cellular environment, many questions remain as to how 
MLOs form, how they are regulated, and how their dysregulation may contribute to 
human disease. The formation and maintenance of membraneless organelles is thought 
to arise through a biological phenomenon called liquid-liquid phase separation (LLPS) 





solution of interacting macromolecules into an energetically favored demixed state. This 
demixed state places liquid droplets, which contains a high concentration of 
macromolecules, in equilibrium with an aqueous solution, which is depleted of the 
macromolecules (Figure 1B) (Alberti and Carra, 2018). These droplets display liquid-like 
properties in that they are spherical in shape, are dynamic, have internal 
rearrangement, and fuse together with contact (Brangwynne et al., 2009). The field has 
recognized LLPS as a functional aspect of cell dynamics and molecular properties for 
many years. Indeed, protein crystallographers are well aware of LLPS, as the process is 
observed frequently at high protein concentrations required for crystallization. 
Nevertheless, the questions of what underpins LLPS, and how this is regulated in cells, 
still remain. 
 
Multivalent interactions maintain phase-separated compartments 
MLOs, with their many macromolecular components, require LLPS as the 
establishment of a network of interactions among macromolecules (Figure 2A) (Alberti 
and Carra, 2018). The network that drives the condensation of phase-separated 
macromolecules consists of multivalent binding domains, which transiently form intra- 
and intermolecular contacts. Here, multivalency refers to dynamically forming non-
covalent interactions between and within phase-separated molecules. Multivalency can 
arise from interactions between both ordered and disordered domains of proteins. 
Intrinsically disordered regions (IDRs), or regions which lack three-dimensional 





conditions (Uversky, 2017). Evidence also supports that structured domains can 
contribute to and modulate LLPS (Dao et al., 2018; Li et al., 2012; Wang et al., 2018). 
FUS family proteins, which exhibit phase separation and have been studied 
extensively, are a good example of proteins with multivalent interactions between 
ordered and disordered regions (Wang et al., 2018). Included in this family are proteins 
FUS, hnRNPA1, and TDP-43, among others. These proteins are characterized together 
because they share similar domain structures. They have two key features: a low 
complexity, prion-like domain (PLD), and an RNA binding domain (RBD) which contain 
folded RNA recognition modules (Malinovska et al., 2013). Together, interactions 
among these domains are believed to work synergistically to drive LLPS. Additionally, 
with nuclear Overhauser effect (NOE) experiments, which are used to determine intra- 
and inter- molecular distances, the Fawzi group observed that all major residue types 
within the FUS PLD participate in interaction contacts, thus supporting the idea that 
FUS forms dynamic, multivalent interactions in its liquid phase (Murthy et al., 2019). 
Underpinning multivalency are classical modes of molecular interactions 
including p—p stacking, cation–p interactions, and charge–charge interactions between 
the proteins’ amino acid side chains (Figure 2B). p—p interactions can form between 
two amino acids which have aromatic side chains. Because aromatic molecules have 
planar geometry and contain delocalized p electrons, these molecules can form 
interactions in a stacked configuration. Several studies have uncovered the critical role 
of  p—p stacking in the phase separation of proteins such as nephrin, FUS, and 
hnRNPA2 (Boeynaems et al., 2017; Pak et al., 2016; Xiang et al., 2015). Charge—





which occurs when a positively charged amino acid interacts with a negatively charged 
amino acid. These electrostatic interactions may arrange the proteins in a configuration 
that favors phase separation (Pak et al., 2016). Cation—p interactions provide points of 
contact between positively charged amino acids (lysine and arginine) and aromatic 
amino acids (tryptophan, tyrosine, and phenylalanine), which are rich in p electrons. 
FUS has emerged as a protein which is dependent on cation—p interactions to maintain 
its LLPS properties (Wang et al., 2018). 
Beyond this, it is sensible that domains which contribute to oligomerization also 
increase the propensity for LLPS. It is thought that oligomerization nucleates a locally 
high concentration of a protein to promote phase separation (Shin et al., 2017). 
Nucleophosmin (NPM1), a protein involved in ribosome biogenesis, for example, 
mediates LLPS with partner proteins through its N-terminal oligomerization domain in a 
pentameric state (Mitrea et al., 2016). Additionally, recent studies suggest that NPM1 
also can mediate LLPS itself via self-association under crowded conditions (Mitrea et 
al., 2018). Speckle-type POZ protein (SPOP) is a protein dependent on its ability to 
oligomerize in order to be recruited to MLOs (Marzahn et al., 2016). Interestingly, 
oligomerization has also been posed as a mechanism of solidification of liquid granules 
(Boke et al., 2016; Kato et al., 2012). Multivalency and oligomerization are currently 
suggested as main principles behind LLPS, however the exact biophysical mechanisms 
which drive molecules to phase separate, and what regulates this, is still under 
investigation.  
 Because of the prominent role multivalency plays in LLPS, researchers in the 





describe these sites of dynamically forming contacts between phase-separated 
molecules. Stickers are the associative motifs which drive LLPS, or sequences that 
contribute to multivalency, and spacers connect the sticker regions (Harmon et al., 
2017; Rubinstein and Dobrynin, 1997; Semenov and Rubinstein, 1998). Importantly, 
spacers can tune LLPS by either enabling or suppressing contact between stickers 
(Martin et al., 2020). 
 
Dysfunction of LLPS leads to pathological states 
 Interestingly, LLPS, and the mechanism of how this transition occurs, may 
predispose MLOs to dysfunction. As a consequence of LLPS, and the network of 
interactions which it requires, MLOs tend to have very crowded and highly concentrated 
environments in comparison to the surrounding cytoplasm. Though these properties are 
necessary for proper, and beneficial, condensation, they can also increase the 
propensity for protein misfolding and aggregation. Additionally, IDRs and multi-domain 
proteins, both of which are common in key phase-separating proteins, increase the 
propensity for dysfunction (Alberti & Carra, 2018). As mentioned before, oligomerization 
may also predispose granules towards maturation to a solidified, dysregulated state 
(Boke et al., 2016; Kato et al., 2012). 
Indeed, various pathological states have been associated with MLO dysfunction. 
For instance, dysregulation within phase-separated MLOs has been closely tied to 
neurological disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal 
dementia (FTD). ALS is a neurodegenerative disease which leads to muscle weakness 





hallmark of ALS is the presence and formation of aggregates which resemble 
cytoplasmic inclusions (Lin et al., 2015). Interestingly, disease-linked mutations in 
proteins such as FUS, hnRNPA1/2, TIA-1, which are recruited to stress granules, 
facilitate a liquid-to -solid transition (Lin et al., 2015; Mackenzie et al., 2017; Patel et al., 
2015). Importantly, each of these proteins undergo LLPS in vitro and in cells. Thus, it is 
suggested that disease-linked mutations alter the LLPS properties of these proteins, 
and may disrupt stress granule dynamics leading to ALS-associated pathological 
inclusions. The investigation of phase-separating proteins which harbor ALS-linked 
mutations has recently been prioritized, as their properties may reveal a central 
pathomechanism. 
 
In vitro analysis of phase-separating protein solutions 
The exact molecular mechanisms which link LLPS, MLOs, and cellular protein 
aggregates has yet to be discovered, and they are likely to be system- and context-
specific. In order to systematically address these questions, our lab and others, have 
directed studies towards identifying the specific interactions underlying LLPS. Using an 
array of biochemical and biophysical techniques, researchers have found that regional 
hydrophobicity, the lack of or presence of ringed amino acids and other amino acid-
based observations, and self-association have been identified as factors that may 
influence LLPS (Dao et al., 2018; Riback et al., 2017; Wang et al., 2018). In order to 
investigate how such variables may alter LLPS properties, a series of experiments can 





First, to screen for phase separation, many labs turn to brightfield microscopy. 
Phase-separated protein solutions contain micrometer sized droplets, which can be 
viewed under a microscope. Here, one can view liquid-like properties and 
characteristics of protein droplets in solution such as fusion events, sphericity, and 
mobility. By quantifying the size of the droplets after a specified amount of time, or the 
time it takes for two droplets to fuse, one can begin to describe the mobility of droplets. 
Fluorescent recovery after photobleaching (FRAP) is another technique often used in 
the field to describe the dynamic nature of phase-separated protein droplets. FRAP 
experiments can be performed on a microscope equipped with the necessary laser, 
where a region of interest is bleached with a laser, and the recovery of fluorescence is 
monitored. In a phase-separated system, this looks like photobleaching a small area of 
a fluorescently tagged protein droplet. The rate at which fluorescence recovers will be 
dependent on the dynamics of the protein exchange between the inside and outside of 
the droplet. For example, if fluorescence recovers quickly, the droplet is liquid-like, 
where if the fluorescence recovers slowly, the droplet is likely more gel-like, or 
aggregate-like. 
Additionally, UV-visible (UV-Vis) spectrophotometry can be used to screen for 
LLPS by measurement of the absorbance of a phase-separated solution. Upon the 
induction of LLPS, often with the addition of salt or a change in temperature, a solution 
will become turbid due to the presence of liquid droplets. Therefore, as droplets appear 
in solution, they scatter light which causes an increase in absorbance. Previous work 
from our lab and others showed that high A600 values are associated with droplet 





al., 2018). Typically, turbidity assays measure absorbance as a function of temperature 
(e.g. from 4oC to 60oC), which begins to map the conditions where the solution phase 
separates into a demixed state. Turbidity assays are also useful as a means to 
construct temperature—concentration phase diagrams.  
The phase-separation field has adopted a method of quantifying LLPS at certain 
conditions through the construction of temperature—concentration phase diagrams 
(Figure 3). Temperature—concentration phase diagrams are valuable in that they map 
the conditions in which a protein solution is fully mixed and when a protein solution is 
demixed, or phase-separated. A technique commonly used to construct phase diagrams 
are temperature ramp turbidity assays, which are used herein and measure the 
absorbance of protein solutions of various concentrations across a specified 
temperature range (e.g. from 4oC to 60oC). At a protein concentration for which no LLPS 
is observed at the start of the experiment, temperature ramping turbidity assays are 
performed to determine Tcp, the temperature at the inflection point of the transition 
(Figure 3A). As this process is repeated over various concentrations, we are able to plot 
each Tcp as a function of protein concentration to construct the low-concentration arm of 
the phase diagram (Figure 3B). The low-concentration arm maps the phase boundary 
between the phase-separated and mixed states. For LCST (lower critical solution 
temperature) phase transitions, the solution changes from clear to turbid as temperature 
increases. Some phase-separating systems also exhibit an upper critical solution 
temperature (UCST), where the solution starts in a demixed state and returns to a fully 
mixed state as temperature increases. By constructing phase diagrams depicting the 





conditions where the solution phase separates. Additionally, in these experiments we 
are able to test variables (such as pH, salt, protein concentration, or protein mutation) to 
quantify how they shift phase-separating conditions.  
As self-association is a prominent mechanism underpinning LLPS, it is also 
important to detect oligomerization states of the protein of interest. Biophysical 
techniques commonly utilized to probe and describe self-association and 
oligomerization of phase-separating proteins are size exclusion chromatography (SEC) 
and small angle x-ray scattering (SAXS). SEC uses a column of tightly packed beads to 
separate solutions based on protein size and shape. Larger molecules, and thus larger 
oligomeric species in the solution will elute more quickly than smaller molecules. SAXS 
measures small angle scattering to determine the size and shape of nanoscale particles 
and macromolecules in solution. If larger oligomeric species are present in the protein 
solution, we would expect to see an increase in scattering intensity (cm-1). Importantly, 
these experiments are performed with protein solutions in a non-phase-separating state.  
An additional technique used to probe phase-separating proteins in vitro is 
nuclear magnetic resonance (NMR) spectroscopy, a technique which uses a magnetic 
field to measure the interaction of nuclear spins to identify molecular content and 
structure. An NMR analysis, chemical shift perturbation (CSP), has classically been 
used to map changes in chemical shifts of resonances in a series of protein 
concentration-dependent NMR spectra, and is used to identify residues that are affected 
by self-association and oligomerization. This technique is especially valuable as it has 
been used to predict “sticker” regions, a framework used to describe associative motifs 





Conversely, “spacers” are the regions which link stickers, and can either support or 
suppress the formation of these interactions to modulate LLPS (Martin et al., 2020). The 
identification of sticker and spacer regions in a phase-separating protein is vital to 
understanding the molecular drivers of LLPS for that system. Ultimately, the techniques 
discussed above allow scientist to probe phase-separating behavior in vitro and analyze 
the contributing factors to LLPS.  
 
Ubiquilin-2 (UBQLN2) phase separates in vitro and is recruited to stress granules 
Our lab has shown that the human protein Ubiquilin-2 (UBQLN2) phase 
separates in vitro under physiological conditions, and is recruited to stress granules 
(Dao et al., 2018) (Figure 4 A&B). UBQLN2, a member of the ubiquilin family, is 66kDa 
and is composed of 624 amino acids. It is one of five known paralogs of UBQLN (-1, -2, 
-3, -4, and -L). UBQLN2 is a protein quality control factor found abundantly in the 
nervous system, and functions to transport ubiquitinated substrates to the proteasome 
for degradation, as well as stress response (Kleijnen, 2000; Walters, 2002; N’Diaye, 
2009). UBQLN2 has an N-terminal ubiquitin-like domain (UBL) which associates with 
the proteasome, and a C-terminal ubiquitin-associating domain (UBA) which associates 
with ubiquitin (Ub) and polyubiquitin (Figure 4C). UBQLN2 also contains two heat shock 
chaperone-binding domains, STI1-I and STI1-II, which associate with chaperone 
proteins like HSP70 to further function in recycling proteins at the proteasome (Hjerpre, 
2016; Kaye, 2000). Our lab recently showed that UBQLN2 features structured domains 
(UBL and UBA) and low-complexity intrinsically disordered regions (IDRs), both of 





the UBA, PXX, and STI1-II domains all contribute to multivalent interactions which drive 
its LLPS (Dao et al., 2018).  
Importantly, UBQLN2 also is implicated in Amyotrophic Lateral Sclerosis (ALS). 
ALS is a proteinopathic disease where cytoplasmic inclusions, or protein aggregates, 
accumulate inside motor neurons. Liquid-liquid phase-separated MLOs like stress 
granules and P-bodies are thought to be precursors to cytoplasmic inclusions (Molliex et 
al., 2015). Notably, UBQLN2 is present in both stress granules and cytoplasmic 
inclusions (Alexander et al., 2018; Deng et al., 2011; Le et al., 2016). Additionally, 
mutations in UBQLN2 have recently been associated with familial ALS (Deng et al., 
2011). Our lab previously characterized 11 disease-linked point mutations of UBQLN2, 
and found that ALS-linked mutations disrupt UBQLN2 phase-separating properties to 
different extents (Dao et al., 2019). Therefore, UBQLN2 is a model system of LLPS 
because of its phase-separating behavior, its link to stress granules, and its involvement 
in disease-linked proteinopathy.  
 
Thesis overview 
 The studies provided here aim to further elucidate the molecular drivers of 
UBQLN2 LLPS. By using an array of techniques including microscopy, temperature—
ramp turbidity assays, construction of temperature—concentration phase diagrams, 
SEC, and SAXS, I look at how mutations to UBQLN2 alter its phase separation, and 
how UBQLN2 domains contribute differently to its phase separation. First, I investigate 
how UBQLN2 stickers and spacers contribute to UBQLN2 LLPS via analysis of a library 





UBQLN2 LLPS via generation and analysis of six domain-deleted constructs. In Chapter 
4 I provide proof of principle that UBQLN2 can be expressed and purified from Sf9 
insect cells, which, importantly, yield post-translationally modified protein. Finally, I 
























Figure 1. Membraneless organelles in cells and LLPS in vitro. (A) Membraneless 
organelles (MLOs) within the cell which arise via LLPS. Depicted here is a non-
exhaustive list of organelles which arise via LLPS. Reproduced from (Gomes and 
Shorter, 2019).  (B) A fully mixed solution of protein (grey) and buffer solution (blue and 
yellow) undergoes LLPS to a demixed state resulting in protein droplets. Below are 
brightfield microscopy images of UBQLN2 diffuse at time=0 in buffer solution and in a 







Figure 2. Determinants of LLPS. (A) Sites of multivalent intra- and intermolecular 
interactions (highlighted in yellow) are critical in driving and maintaining a phase-
separated state between protein molecules (purple). (B) Depicted here is a protein 
phase-separated droplet (left) where purple represents protein molecules, and intra- 
and intermolecular interactions (stickers) are highlighted in yellow. View of droplet is 
zoomed in (right) to observe the interactions which contribute to multivalency. This non-
exhaustive list of interactions important in multivalency includes charge-charge, cation-







Figure 3. Temperature-concentration phase diagrams used to quantify LLPS. (A) 
Temperature—ramp spectroscopic data (colored lines) are fit with Four Parameter 
Logistic Regression analyses to determine the cloud point temperature (Tcp) at the 
inflection point of the transition at each concentration (in µM). (B) The LCST phase 
transition curve is mapped by plotting each Tcp, where the colored dots represent the 




































































Figure 4. UBQLN2 phase separates in vitro and is recruited to stress granules in 
cells. (A) Brightfield microscopy of WT UBQLN2 in buffer containing 20 mM 
NaPhosphate and 200 mM NaCl (pH 6.8) at 37 C using 100 μM protein. (B) 
Immunostaining for endogenous UBQLN2 in U2OS cells shows that UBQLN2 is diffuse 
in cytoplasm, but form puncta under stress condition tested. UBQLN2 colocalizes with 
eIF4G1, a stress granule (SG) marker. DAPI is used to stain nuclei. (adapted from Dao 
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In this chapter, I present my contributions to the manuscript. These include all 
microscopy and droplet fusion experiments, size exclusion chromatography, protein 
purification, and writing and editing of the final manuscript. Additionally, I completed 
small angle x-ray scattering (SAXS) experiments, including protein sample preparation 
and data analysis, while experiments were collected at NIST (Gaithersburg, MD) by Dr. 
Alex Grishaev. SAXS data were not included in the published article, but are presented 








UBQLN2 450−624 oligomerizes and undergoes temperature-responsive liquid−liquid 
phase transitions following a closed-loop temperature−concentration phase diagram. 
We recently showed that disease-linked mutations to UBQLN2 450−624 impart highly 
varying effects to its phase behavior, ranging from little change to significant decrease 
of saturation concentration and formation of gels and aggregates. However, how single 
mutations lead to these properties is unknown. Here, we use UBQLN2 450−624 as a 
model system to study the sequence determinants of phase separation. We 
hypothesized that UBQLN2 450−624 regions previously identified to promote its 
oligomerization are the “stickers” that drive interchain interactions and phase 
separation. We systematically investigated how phase behavior is affected by all 19 
possible single amino acid substitutions at three sticker and two “spacer” (sequences 
separating stickers) positions. Overall, substitutions to stickers, but not spacers, 
substantially altered the shape of the phase diagram and dense phase material 
properties. Within the sticker regions, increasing hydrophobicity decreased saturation 
concentrations at low temperatures and enhanced oligomerization propensity and 
viscoelasticity of the dense phase. Conversely, substitutions to acidic residues at all 
positions greatly increased saturation concentrations. Our data demonstrate that single 











Liquid-liquid phase separation (LLPS) is a physical process whereby a fully 
mixed solution demixes into two different liquid states (Hyman et al., 2014). However, 
the exact mechanism which underpins this process is largely unknown. Emerging 
evidence points to a multitude of variables which work together to drive phase 
separation and tune its behavior. In a majority of phase-separating proteins, 
multivalency among intrinsically disordered regions and/or folded domains form the 
framework of protein phase separation (Banani et al., 2016; Li et al., 2012; Wang et al., 
2018). Here, multivalency refers to multiple, non-covalent, reversible crosslinks that 
form among “sticker” regions in macromolecules. These multivalent interchain 
interactions (often present intrachain as well) are driven by properties of amino acids. 
For instance, amino acids possessing a positive charge can interact with aromatic 
amino acids to form cation-p interactions. Likewise, different types of amino acids 
contribute to p—p stacking interactions, hydrophobic, and electrostatic interactions. 
Examples of these can be found in phase-separating proteins FUS, Pab1, and TDP-43, 
and Ddx4. Phase-separating proteins in the FUS family, for example, are highly 
dependent on cation-p interactions, while proteins like Pab1 display hydrophobic 
interactions which drive their LLPS (Riback et al., 2017b; Wang et al., 2018b). DNA-
binding protein, TDP-43, is highly dependent on aromatic residues for its ability to phase 
separate (Li et al., 2018). Charged residues in Ddx4 contribute to electrostatic 
interactions which contribute to its phase separation (Nott et al., 2015). These findings 





it is hypothesized that phase-separating behavior is encoded in the amino acid 
sequence. 
In this study, we created a system to which we could experimentally map the 
effects of single amino acid mutations in sticker and spacer regions on LLPS behavior. 
Using a C-terminal construct of UBQLN2 450C, we recently determined residues that 
were involved in self-association, or oligomerization (Dao et al., 2018). These residues 
were identified using concentration-dependent chemical shifts from NMR spectroscopy. 
The shortened C-terminal construct of UBQLN2 was chosen for analysis because its 
small size (∼175 amino acids) enabled the use of nuclear magnetic resonance (NMR) 
spectroscopy to monitor backbone amide chemical shifts as a function of protein 
concentration on a residue-by-residue basis.  Significant concentration-dependent 
chemical shifts were observed for residues 450-509, 555-570, 592-596, and 615-620, 
meaning that these sites contribute to self-association (Figure 1A) (Dao et al., 2018). 
With these data we hypothesized that these regions act as sites of multivalent 
interactions, and therefore drive UBQLN2 phase separation. Using the “sticker” and 
“spacer” framework we have predicted these sites to be stickers, which are the motifs 
that drive LLPS (Harmon et al., 2017; Rubinstein & Dobrynin, 1997). The amino acids 
which comprise the sticker regions are largely hydrophobic and polar (Figure 1B). The 
regions in between stickers are characterized as spacers. Spacers impart flexibility and 
can tune LLPS behavior.  
We hypothesized that introducing mutations to sticker regions would significantly 
affect phase-separating properties, while mutations to spacers would affect phase-





saturation concentration (csat), and droplet morphology and droplet fusion kinetics in 
UBQLN2 constructs with mutated sticker positions. To test this hypothesis, we 
generated all 19 possible amino acid substitutions at three sticker residues and two 
spacer residues in the UBQLN2 450C background. We considered positions P497, 
P506, and V564 as “stickers”, and positions P525 and V538 as “spacers”. The resultant 
95 constructs were subjected to temperature ramp turbidity assays to determine their 
saturation concentration, droplet morphology and kinetic studies via microscopy and 
droplet fusion assays, and self-association was observed via size exclusion 
chromatography (SEC) and small angle x-ray scattering (SAXS). Our data corroborate 
the hypothesis that sticker regions drive UBQLN2 phase separation given that sticker 
substitutions substantially altered temperature—concentration phase diagrams, droplet 
morphology and self-association propensity, whereas spacer substitutions altered these 
only marginally. Additionally, we show that individual amino acid substitutions modify 
phase transitions, and therefore show that phase-separating behavior is encoded in the 
amino acid sequence. With these data we hope to develop computational models 
and/or simulation to determine the molecular driving forces of phase separation.  
 
Results  
Turbidity assay analyses describe effect of amino acid substitutions 
Temperature ramp turbidity assays were used to screen the experimental 
conditions, specifically protein concentration, for each mutant construct to undergo 
LLPS (Figure 2). We monitored the change of absorbance between 16 and 60°C of 





that high A600 values are associated with droplet formation, while lower absorbance 
values are associated with droplet clearance (Dao et al., 2018). These experiments 
were also used to construct temperature—concentration phase diagrams (Figure 3). WT 
UBQLN2 exhibited a LCST and a UCST, indicating two temperature-responsive phase 
transitions between 16 and 60°C (Figure 3A). As temperature increases from 16 to 45°C 
UBQLN2 demixes into phase-separated droplets, and as temperature further increases 
from 45C to 60°C UBQLN2 returns to its fully mixed state. The first transition is a LCST 
transition, which means that there is a lower critical solution temperature (LCST) below 
which the solution is always mixed, and the second transition is a UCST transition, 
which means that there is an upper critical solution temperature (UCST) above which 
the solution is always mixed. Construction of turbidity profiles and phase diagrams allow 
for characterization of the conditions where phase transitions occur to compare across 
different protein samples. 
We introduced amino acid substitutions at three sticker positions (497, 506, and 
564) and two spacer positions (525 and 538) in UBQLN2 450C. First, using a fixed 
protein concentration of 50 μM, we screened their phase-separating conditions using 
turbidity assays (Figure 2). Phase diagrams were constructed at two representative 
positions, a sticker (506) and a spacer (538), for each amino acid mutation.  Across all 
positions, we initially noticed several major trends. When compared to the wild type 
amino acid at each position (proline at positions 497, 506, and 525, and valine at 
positions 525 and 538), substitutions impacted phase separation to different degrees 
(Figure 2, Figure 3B). In both turbidity assays and phase diagrams, substitutions to 





LLPS was first observed, or the LCST phase transition. As hydrophobicity increased 
with amino acid substitution, the protein concentration (csat) required for LLPS 
decreased and coexistence curves shifted to the left. Sticker position substitutions also 
widened the temperature range at which LLPS is observed. In contrast, spacer position 
substitutions generally reveal similar turbidity trends as wild type, except for some 
amino acid substitutions such as acidic amino acids D and E. Strikingly, temperature—
concentration phase diagrams recapitulate general observations seen in our initial 
turbidity profiles. Here, we note that introducing mutations to UBQLN2 sticker position 
506 shifted the position of the phase diagram and also changed the overall shape. In 
contrast, mutations at spacer position 538 generally left the phase diagram unchanged, 
with only mild perturbations from WT UBQLN2. These observations are consistent with 
our hypothesis that residues 497, 506, and 564 reside in sticker regions, where 525 and 
538 are in spacer regions.  
Beyond these general observations, there is considerable variation in droplet 
formation among the different types of amino acid substitutions. Our turbidity and phase 
diagram data are presented as amino acid type in decreasing hydrophobicity (Figure 2, 
Figure 3C). First, we have grouped amino acids by type: aromatic (F, W, Y), 
hydrophobic (A, G, I, L, M, P, V), polar (C, N, Q, S, T), basic (H, K, R), and acidic (D, E). 
We then organized these groups according to an experimentally determined 
hydrophobicity scale (Urry et al., 1992). We note the complication in assigning residues 
to these classes, particularly  glycine and proline, due to their roles in modulating 
protein structure via flexibility and solubility (Holehouse and Pappu, 2018). Interestingly, 





temperature and protein concentration needed for LLPS. This is especially seen with 
aromatic substitutions, where the threshold for UBQLN2 LLPS is below 16°C. Notably, 
slight differences between sticker positions and amino acid type were observed. For 
instance, UBQLN2 mutants with Ile or Phe substitutions at position 506 remained turbid 
for the entire temperature range (16−60°C) at 50 μM, whereas phase-separating 
solutions of P497F and P497I began clarifying at 40°C. These observations illustrated 
that Ile and Phe substitutions to both P497 and P506 impact LCST and UCST phase 
transitions but via different mechanisms. Spacer position mutations did affect UBQLN2 
LLPS, however to a much lesser extent. Spacer mutations generally showed the same 
trend regarding the temperature onset of phase separation, however the absolute 
intensity of the absorbance signal increased after introducing a mutation, especially to 
aromatic and hydrophobic residues. It is possible that aromatic and hydrophobic 
residues increase sticker-like interactions, hence increasing the degree of phase 
separation of the solution. Interestingly, acidic mutations at both stickers and spacers 
greatly reduced the ability of UBQLN2 to phase separate. Together, these data show 
that LLPS properties are highly dependent on amino acid sequence, both in type of 
amino acid and position. Specifically, these data suggest the importance of hydrophobic 
amino acids in promoting UBQLN2 intermolecular interactions and driving its phase 
separation. Consistent with this idea, many amino acids found in sticker regions of 
UBQLN2 are hydrophobic. 
 






Mapping phase diagrams allowed us to elucidate the effects of the substitutions 
on phase transitions and determine driving forces for UBQLN2 phase separation. In 
order to evaluate the consequences of substitutions on the dense phase we first used 
brightfield microscopy to investigate the morphology of UBQLN2 droplets. To do this, 
we chose representative substitutions of each amino acid type including W (aromatic), 
G and L (hydrophobic), R (basic), Q (polar), and E (acidic) across all five positions 
studied (Figure 4). In general, droplet morphologies correlated well with turbidity assay 
results. Mutants with turbidity profiles similar to WT UBQLN2 also displayed spherical 
droplets of similar size as WT UBQLN2. Those mutations which resulted in significantly 
increased turbidity or shifted phase diagrams, such as aromatics and hydrophobics in 
sticker positions, also generally formed amorphous droplets. This was exhibited with 
mutants P497W, P497L, P506W, and P506L. Mutant P497Q, which appeared to form 
visible aggregates during turbidity assays, also exhibited aggregate-like morphology 
when viewed under the microscope. Acidic mutation E, which displayed little turbidity 
across all positions, formed small and dispersed aggregate-like species. Interestingly, 
after 30 minutes at these conditions, V538E showed the presence of spherical droplets 
after first appearing only as small aggregates. Consistent with our hypothesis, spacers 
(with the exclusion of P525R, P525E, and V538E) had minimal effects on droplet 
morphology, while sticker position substitutions showed a greater susceptibility to alter 
droplet dynamics and morphology. Future experiments will investigate the role of E and 
R mutations on droplet assembly kinetics and morphology. 
To quantitatively describe the effects of sticker and spacer mutations on the 





measured the time it took for two fusing droplets to return to a spherical shape. We 
analyzed the rates of droplet fusions since the sphericity of droplets reports on surface 
tension and viscosity (Feric et al., 2016). For WT UBQLN2, two fusing droplets relax 
into one spherical droplet within seconds (Figure 4B). However, we observed that other 
mutations relaxed at a slower rate, while some did not achieve a spherical shape within 
a 3 minute experimental window (Figure 4B and 4C). Relaxation times were extracted 
for each amino acid type, at a representative sticker position, 506, and at a 
representative spacer position, 538. Consistent with our sticker-spacer hypothesis, 
V538 mutants all fused with similar relaxation times as WT UBQLN2, despite the type of 
amino acid substitution. In contrast, position 506 mutants varied in relaxation times 
based on the amino acid substitution. Polar and ionizable substitutions fused quickly, 
like WT. However aromatic and hydrophobic substitutions substantially slowed droplet 
relaxation. Again, these data suggest that hydrophobic and aromatic amino acids 
significantly impact UBQLN2 phase separation. 
 
Effects of amino acid substitutions on LLPS properties can be explained by changes in 
oligomerization propensity 
Previous work from our lab highlighted the importance of oligomerization in 
phase separation. Because of this, we probed UBQLN2 self-association via size 
exclusion chromatography (SEC) under non-phase-separating conditions. We 
previously demonstrated that UBQLN2 at low concentrations (up to ~100 μM) is 
monomeric, but at higher concentrations (~500 μM) UBQLN2 forms large oligomers 





μM, SEC elution volumes decreased, as expected for UBQLN2 oligomerization (Figure 
5). Therefore, we subjected representative mutants at each position to SEC using 
concentrations of 10, 100 and 500 μM (Figure 5).  
All representative substitutions, across all positions, exhibited concentration-
dependent oligomerization; increasing protein concentrations led to a decrease in 
elution volume (Figure 5). Again, consistent with our hypothesis, the SEC experiments 
for the spacer mutations were similar to those for WT UBQLN2. P525E was the only 
exception, as a small population of a large species eluted early in the SEC experiment. 
This is consistent with microscopy data, as P525E showed the most aggregates out of 
all other E mutants. At sticker positions 497 and 506 both W and L substitutions 
oligomerized substantially more than WT. At sticker position V564, W and L appeared to 
oligomerize more than WT but not as substantially as at other sticker positions. We 
suspect this difference is due to the fact that the WT amino acid at this position, valine, 
is already hydrophobic. These data further suggest that aromatic and hydrophobic 
residues promote UBQLN2 LLPS, as these substitutions also promote oligomerization 
and thus intermolecular interactions. 
 
SAXS analysis confirms presence of large oligomers in stickers 
To corroborate SEC conclusions, we also subjected representative UBQLN2 
mutants to analysis via small angle x-ray scattering (SAXS). SAXS is a technique 
classically used to determine size and shape of nanoscale particles and 
macromolecules in solution through a measure of light scattering angles. Here, SAXS is 





larger oligomeric species are present in the protein solution, we would expect to see an 
increase in scattering intensity (cm-1). Our studies herein pose that we will observe 
larger oligomeric species with increases in concentration and temperature, as well as 
with hydrophobic “sticker” UBQLN2 substitutions. In these experiments, we looked at 
WT UBQLN2 450C and mutations to sticker positions 497 and 506. We chose 497L 
because of its tendency to phase separate at lower temperatures and protein 
concentration as compared to WT, and we chose glutamic acid mutations because of 
their tendency to experience very little phase separation. We also did these experiments 
at two temperatures to show the relationship between oligomerization and temperature. 
Completely in line with our predictions, WT UBQLN2 had increased scattering intensity 
with increasing concentration (100 μM to ~250μM) and increasing temperature (4°C and 
25°C) (Figure 6A). Additionally, leucine substitutions in sticker positions P497 and P506 
drastically enhanced scattering when compared to WT at the same concentration 
(Figure 6B). The acidic substitution glutamic acid, at sticker positions 497 and 506, had 
a similar scattering profile as WT, which supports data from SEC (Figure 6C). All protein 
solutions displayed increased scattering with increased temperatures, consistent with 
previous data which describes oligomerization as a prerequisite for LLPS (Dao et al., 
2019). These results together confirm the role of self-association in UBQLN2 LLPS—








Discussion and Conclusions 
 Here, we have demonstrated that UBQLN2 phase separation can be modulated, 
to different extents, by single amino acid substitutions. The observations herein provide 
evidence that both substitution position and amino acid type are important in tuning the 
behavior of UBQLN2 LLPS. These data demonstrate that the sticker-spacer framework 
is useful in predicting the driving motifs of phase separation. Substitutions at sticker but 
not spacer positions elicited major changes to the overall shape and characteristics of 
the phase diagram, droplet morphologies and viscoelascity, and self-association. 
Therefore, we can conclude that stickers drive phase-separating properties, where 
spacers modulate LLPS to a lesser degree. Beyond this, we also confirmed trends 
across types of amino acids. It was observed that bulky aromatic, hydrophobic and 
some polar amino acids tend to alter LLPS properties more substantially than others. 
This was especially true from analyzing the strikingly different droplet morphologies and 
viscoelastic properties in the sticker position P506. Additionally, acidic mutations elicited 
major changes in phase separation by greatly increasing saturation concentration, 
which notably, occurred in both sticker and spacer substitutions. Because acidic 
mutations impart a negative charge similarly to a phosphate group, this specific finding 
highlights the potential impact of post-translational modifications such as 
phosphorylation on modulating phase separation behavior. 
 With these combined data, we have determined that UBQLN2 LLPS is driven by 
the hydrophobic effect and polar interactions. The interactions posed by these 
substitutions add to UBQLN2’s overall multivalency.  It is thought that the introduction of 





idea can be justified through self-association studies provided herein—those mutations 
which showed major deviation from WT in droplet morphology also showed the 
presence of higher-order oligomeric species. The particular trends witnessed in these 
experiments address a rich molecular code which governs UBQLN2 LLPS. Our work 
here provides a rich data set to be used as a benchmark for analytical and 








Figure 1. UBQLN2 450C experimental sticker residues and composition. (A) CSPs 
represent residue-specific chemical shift differences between low (45µM) and high (600 
µM) protein concentrations. Grey bars mark resonances only visible at 45µM. Domain 
map marks residues that exhibit concentration-dependent peak broadening or 
significant CSPs. All spectra were collected at 25°C in pH 6.8 buffer under non-LLPS 
conditions. Experimental sticker residues are highlighted and marked with asterisks in 
red, and experimental spacer residues are highlighted and marked with asterisks in 
blue. (B) Fraction of different types of amino acids in UBQLN2 450C, which is high in 
polar, hydrophobic, glycine and proline residues, and depleted in charged and aromatic 
residues. (C) UBQLN2 450C sequence where residues highlighted in color are found in 
sticker regions with colors corresponding to its type of amino acid. Sticker regions are 









Figure 2. Turbidity profiles at sticker and spacer positions. Results from 
spectrophotometric turbidity assay as a function of temperature comparing LLPS of 
different UBQLN2 mutants using 50 μM protein in 20 mM NaPhosphate and 200 mM 
NaCl (pH 6.8). The blue asterisks represent WT UBQLN2 turbidity profile for each 
position. The red asterisks represent mutants that form unevenly distributed aggregates 
at one point during the assay. P497H, S, N, and Q formed aggregates early in the 
experiment, whereas P506N and Q aggregated at temperatures above 44 °C. Turbidity 
profiles of amino acid substitutions at each position are separated by amino acid type: 
aromatic, hydrophobic, basic, polar, and acidic. Hypothesized stickers and spacers are 












Figure 3. Temperature−Concentration phase diagrams for representative sticker 
and spacer residues in UBQLN2. (A) Schematic of a closed-loop phase diagram 
showing both UCST and LCST behaviors. The black dots represent the experimental 
data points for the low concentration arm obtained in this study to partially map the 
phase diagram. (B) Effects of amino acid substitutions in the sticker (pink, P506) region 
and in the spacer (cyan, V538) region compared to WT UBQLN2 (black). Circled in 
black are D and E mutants for each position. (C) Effects of amino acid substitutions 
separated by amino acid type: aromatic (F, W, Y), hydrophobic (A, G, I, L, M, P, V), 
basic (H, K, R), polar (C, N, Q, S, T), and acidic (D, E). The dashed lines are guides that 
connect the UCST phase transition cloud-point temperatures to the LCST ones. Both 
arms of P506N and the UCST arm of P506Q are missing due to formation of 
aggregates during the assays. The UCST arms for V538W, V538Y, V538R, V538K, 
P506D, and P506E are missing, since we observed either no turbidity or nonzero 
















































Figure 4. Amino acid substitutions in the sticker, but not spacer, regions affect 
droplet properties. (A) Light microscopy of different UBQLN2 mutants over 10 and 30 
min at 37 °C using 100 μM protein at sticker (P497, P506, V564) and spacer (P525, 
V538) positions. Scale bar = 5 μm. (B) Snapshots of droplet fusion over a nine second 
window (for WT and V538L and V538W) and a 36 s window (for P506L and P506W), 
indicating differences in droplet fusion kinetics between substitutions at a sticker 
position (P506) and a spacer position (V538). Droplets were imaged 10 min after 
incubating 100 μM protein (except for P506W (25 μM), P506E and V538E (300 μM)) at 
37 °C in buffer containing 20 mM NaPhosphate and 200 mM NaCl (pH 6.8). Scale bar = 
2 μm. (C) Average characteristic relaxation times for WT and mutant droplet fusion. 









Figure 5. Oligomerization propensities of different UBQLN2 mutants. 
Representative SEC profiles of UBQLN2 mutants at 10 μM (thinnest line), 100 μM 
(medium-thick), and 500 μM (thickest) protein concentrations. For each mutant, WT 









Figure 6. Small angle x-ray scattering (SAXS) experiments reveal scattering 
intensities of WT and mutant UBQLN2. (A) WT 4°C 100 μM (aqua), WT 25°C 100 μM 
(red), WT 4°C 254 μM (blue), WT 25°C 254 μM (green). (B) P497L (red), P497E 

































Materials and Methods 
Subcloning, Protein Expression, and Purification 
UBQLN2 mutants were generated from UBQLN2 450-624 using Phusion Site-Directed 
Mutagenesis Kit (Thermo Scientific). A tryptophan codon was added to the C-terminal 
end of all constructs to facilitate determination of protein concentration. UBQLN2 450-
624 and all the mutants were expressed and purified as described in (Dao et al., 2018). 
Briefly, the constructs were expressed in E. coli Rosetta 2 (DE3) pLysS cells in Luria-
Bertani (LB) broth at 37°C overnight. Bacteria were pelleted, frozen, lysed, then purified 
via a “salting out” process. NaCl was added to the cleared lysate to the final 
concentration of 0.5 M - 1 M. UBQLN2 droplets were pelleted and then resuspended in 
6 M urea, 20 mM NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3 (pH 6.8). 
Leftover NaCl and urea were removed through HiTrap desalting column (GE 
Healthcare). All the cysteine mutants were subjected to size exclusion chromatography 
over a Superdex 75 HiLoad 16/600 column (GE Healthcare) or an ENrichTM SEC 650 10 
x 300 column (Biorad) to remove dimer contaminations. SDS-PAGE gels were 
performed to confirm the purity of the proteins. The identity and molecular weight of 
each mutant was verified using electrospray mass spectrometry in positive mode on a 
Shimadzu 8040 MS. Purified proteins were frozen at −80°C. 
 
Spectrophotometric Absorbance/Turbidity Measurements 
Protein samples were prepared by adding protein (from stock to a final concentration of 





NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3) containing 200 mM NaCl 
and were kept on ice for at least 5 minutes before the assay. Absorbance at 600 nm 
was recorded as a function of temperature by a Beckman DU-640 UV/Vis 
spectrophotometer using a temperature ramp rate of 2°C/min increasing from 16°C to 
60°C and then ramped down to 16°C. Net absorbance values were recorded after 
subtracting the absorbance value of a buffer control. Results were averaged from data 
collected using proteins from at least two separate preps and four trials for each (total n 
≥ 8). Data were plotted using Mathematica (Wolfram Research). 
 
Phase diagram measurements 
For the LCST (lower critical solution temperature) phase transition, i.e. mapping the 
phase boundary as temperature is increased, protein samples were prepared as 
described for the turbidity measurements. For the UCST (upper critical solution 
temperature) arm, protein samples were prepared by mixing protein and buffer/salt 
solutions that were incubated at 63°C for at least 10 minutes. Absorbance at 600 nm 
was recorded as a function of temperature by a Beckman DU-640 UV/Vis 
spectrophotometer using a temperature ramp rate of 2°C/min decreasing from 60°C to 
16°C. Two trials (n = 2) were conducted using four to five different concentrations of 
wild-type and mutant UBQLN2 450-624 proteins for each arm. The protein 
concentrations were chosen to cover as wide a range as possible to allow observation 
of phase separation during the temperature ramps but not at the starting temperatures 
(16°C and 60°C for LCST and UCST arms, respectively). Cloud point temperatures 





 $ = & +	 ()*
+,-./0
1  (Equation 1) 
Cloud point temperatures used were the point of inflection (c). Cloud point temperatures 
were then used to define the coexistence curve as a function of protein concentration. 
The temperature ramp rate was either 1°C or 2°C/min, whichever yielded the most 
reproducible, consistent turbidity profiles and phase diagrams. Fitting and plotting of 
data were done with Kaleidagraph (Synergy Software). 
 
Bright-field Imaging of Phase Separation 
UBQLN2 450-624 constructs were prepared to contain 100 μM protein in 20 mM 
NaPhosphate, 200 mM NaCl, 0.1 mM TCEP,and 0.5 mM EDTA (pH 6.8). Samples were 
added to MatTek glass bottom dishes that had been coated with 5% bovine serum 
albumin (BSA) to minimize changes as a result of surface interactions, and incubated at 
37 oC. Phase separation was imaged on an ONI Nanoimager (Oxford Nanoimaging Ltd, 
Oxford, UK) equipped with a Hamamatsu sCMOS ORCA flash 4.0 V3 camera using an 
Olympus 100×/1.4 N.A. objective. Images were prepared using Fiji (Schindelin et al., 
2012) and FigureJ plugin (Mutterer and Zinck, 2013). 
 
Droplet Fusion Assays 
UBQLN2 450-624 constructs were prepared to contain 100 μM protein in 20 mM 
NaPhosphate, and 0.5 mM EDTA (pH 6.8), with the exception of P506W at 25 μM 
protein and P506E and V538E at 300 μM protein. Samples were added to MatTek glass 
bottom dishes that had been incubated with 5% BSA (to minimize changes as a result 





addition of NaCl to a final concentration of 200 mM. After 10 minutes of incubation, 
droplet formation was imaged as time-lapsed sequences for three minutes on an ONI 
Nanoimager (Oxford Nanoimaging Ltd, Oxford, UK) equipped with a Hamamatsu 
sCMOS ORCA flash 4.0 V3 camera using an Olympus 100×/1.4 N.A. objective. Five 
trials were performed for each mutant. Droplets chosen for analysis were of similar size 
and ranged between 2 and 4 microns, except for V538E (8 microns) and P506E (5 
microns). For each mutant, eight fusion events were chosen for analysis and saved as 
separate .tif images including frames from the initial fusion event.  
Relaxation times (time it takes for two fusing droplets to return to a round shape) 
were determined by manually measuring the major axis (a) and the minor axis (b) in 
pixels using Fiji software (Schindelin et al., 2012) and calculating the aspect ratio as 
(a)=a/b.(Schindelin et al., 2012) We monitored the fusion events in this way until the 
droplets reached their most relaxed state, or until the aspect ratio was approximately 
equal to 1. The aspect ratio for each fusion event was fit to an exponential decay curve 
in Matlab (Mathworks). 
$ = 	 (34))6∗8	 + 9 (Equation 2) 
where 34 is the initial aspect ratio, : is time, and 1/= gives the characteristic relaxation 
time. 
 
Size Exclusion Chromatography (SEC) 
Purified UBQLN2 constructs at different concentrations (10 μM, 100 μM, 500 μM) were 
subjected to chromatography over a ENrichTM SEC 650 10 x 300 column (Biorad) on a 





temperature using 1 mL/min flow rate in pH 6.8 buffer containing 20 mM NaPhosphate, 
0.5 mM EDTA, 0.1 mM TCEP with no added NaCl. 
 
Small Angle X-ray Scattering (SAXS) 
Purified UBQLN2 constructs were prepared in pH 6.8 buffer containing 20 mM 
NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP with no added NaCl. SAXS experiments 
were performed at NIST (Gaithersburg, MD) by Dr. Alex Grishaev. SAXS data analysis 
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The human protein UBQLN2 undergoes temperature-responsive liquid-liquid phase 
separation driven by sticker amino acid sequences which contribute to intra- and 
intermolecular multivalent interactions. Previously, hydrophobicity and enhanced 
oligomerization have been identified as drivers of UBQLN2 phase separation. 
Additionally, it was demonstrated by single amino acid substitutions, that UBQLN2 
follows a molecular code to tune phase behavior. However, how UBQLN2 domains 
contribute to this behavior is unknown. UBQLN2 features a mix of structured, disordered 
low-complexity regions, and prion-like regions. All of these regions are believed to 
modulate phase behavior via different mechanisms. In this study, we created six N-
terminally domain deleted constructs in order to investigate the role of UBQLN2 
domains and linkers in its phase separation. By obtaining temperature-concentration 
phase diagrams, we determined that some domain deletion constructs promoted phase 
separation while others inhibited phase separation. Additionally, two representative 
disease-linked mutations were introduced to these constructs, and we found that 
mutations further modulate the phase boundaries for UBQLN2 phase separation. We 
propose that domain deletion constructs may differentially expose or conceal sticker 
sequences, which then modulates its phase separation behavior. The investigation of 
these constructs creates the opportunity to mimic various bound states of UBQLN2 in 
the cell. We speculate that UBQLN2 phase separation will be modulated as UBQLN2 







In the cell UBQLN2 acts as a proteasomal shuttle factor through the ubiquitin-
proteasome system and autophagy (Ko et al., 2004). Misfolded proteins and/or proteins 
destined for degradation are covalently modified with ubiquitin (ubiquitination) and later 
bound to UBQLN2. UBQLN2 then shuttles these proteins to the proteasome to be 
recycled by the cell. This one function of UBQLN2 portrays its different “binding states” 
in the cell. First, unbound, full length UBQLN2 likely exists in the cytosol. Next, 
UBQLN2’s ubiquitin-associated (UBA) domain binds the ubiquitin tag of the protein 
marked for degradation (Ko et al., 2004). Then, the ubiquitin-like (UBL) domain binds 
the regulatory cap of the 26S proteasome (Ko et al., 2004). In this scenario, UBQLN2 is 
observed in three different bound states: 1) unbound 2) ubiquitin-bound and 3) ubiquitin 
and proteasome bound (Figure 1A). As presented in previous chapters, UBQLN2 alone 
phase separates under physiological conditions (Dao et al., 2018). As UBQLN2 phase-
separating properties are highly dependent on multivalent interactions among amino 
acids in its sequence, it is expected that domain interactions with other binding partners 
would modulate UBQLN2 phase separation properties. Upon binding, domains of 
UBQLN2 are no longer available to partake in interactions driving and modulating LLPS. 
Therefore, it is important to identify how different domains may contribute to or modulate 
UBQLN2 LLPS behavior. 
 In addition to shuttling proteins to the proteasome for degradation, UBQLN2 
functions in other protein quality control (PQC) mechanisms. Via UBQLN2’s central 
STI1 domains, UBQLN2 binds chaperone proteins, autophagy components, and 





Yun Lee et al., 2013). Evidence suggests that UBQLN2 associates with HSP70, a 
stress-induced protein involved in disaggregase machinery, via the middle STI1 
domains in order to chaperone misfolded proteins to the proteasome (Hjerpe et al., 
2016). Corroborating this, mutations to UBQLN2 hindered association with HSP70 
chaperone proteins (Hjerpe et al., 2016). Additionally, UBQLN2 is believed to bind Stch, 
a heat-shock protein similar in structure and sequence to HSP70 (Kaye et al., 2000). As 
a part of the ubiquilin family, UBQLN2 shares high sequential similarity with its 
homologs UBQLN1 and UBQLN4. UBQLN1 also associates with proteins BCLb and 
LC3, an anti-apoptotic protein and an autophagy component, respectively via 
UBQLN1’s middle STI1 domains, therefore UBQLN2 may interact with these same 
proteins as well (Beverly et al., 2012; Kurlawala et al., 2017). Figure 1A highlights the 
domain architecture of UBQLN2, and its associations with potential binding partners. 
 UBQLN2 contains both structured domains and intrinsically disordered low-
complexity domains (LCDs). Intrinsically disordered LCDs are domains which do not 
hold a fixed three-dimensional structure. Its 71-residue UBL and 44-residue UBA 
domains are structured and function in the ubiquitin-proteasome system, and both have 
been biophysically characterized (Figure 1) (Walters et al., 2004; Zhang et al., 2008). 
The majority of the rest of the sequence (residues 1-58, 105-267, 283-363, 373-466, 
and 486-586) is predicted to be disordered based on the average of three disorder 
prediction algorithms (Figure 1B) (Li et al., 1999; Obradovic et al., 2003; Romero et al., 
1997; Xue et al., 2010). Often, disordered LCDs are important drivers for the phase 
separation of macromolecules, but both folded and disordered domains contribute to 





maturation of phase-separated droplets into pathological fibrils (Molliex et al., 2015). 
Depending on the phase-separating system, domains with three-dimensional structure 
can contribute to or drive phase separation, though their exact role is currently unclear 
(Milkovic et al., 2020). Interestingly, NMR studies identified structured and unstructured 
domains (UBA, PXX, and STI1-II) that contribute to UBQLN2 self-association, and 
mutational studies confirmed these as driving regions of phase separation (Dao et al., 
2018; Yang et al., 2019). Beyond these C-terminal regions, UBQLN2 offers other 
distinct sequence regions which likely contribute to its phase-separating profile. PLAAC 
prion predictions suggest prion-like domains between linker residues 105-143, linker 
and STI1-II residues 337-461, and residues 555-574. Prion-like sequences are 
classically thought to be especially prone to aggregation (Figure 1B) (Lancaster et al., 
2014; Sabate et al., 2015). Notably, recent findings suggest that prion-like sequences 
have chaperone-like functions and are a key regulator of LLPS by enhancing self-
association (Franzmann and Alberti, 2019). A phase separation predictor algorithm, 
from the Forman-Kay group, is based on amino acid propensity for p-p contacts and 
predicts UBQLN2 to phase separate (Fig 1B) (Vernon et al., 2018). Here, positive P-
score values represent a higher probability of phase separation. Interestingly, the higher 
P-score values are seen in all linker regions of UBQLN2. As we investigate UBQLN2 
LLPS, it is vital to understand how such features contribute to its phase-separating 
ability. 
 Furthermore, elucidating how disease-linked mutations modulate domain-domain 
interactions could further inform on the mechanism of UBQLN2 LLPS and how 





mutations at positions 487, 497, and 506 using the C-terminal construct UBQLN2 450-
624 (Dao et al., 2019). These mutations altered UBQLN2 450C phase separation in that 
they 1) lowered phase transition temperatures and decreased saturation concentrations 
(csat) necessary for LLPS, 2) disrupted droplet morphology wherein some cases gel-like 
and amorphous aggregates were observed, and 3) increased oligomerization propensity 
of UBQLN2. Interestingly, in a preliminary study, we found that the same mutations in 
full length UBQLN2 altered LLPS to a much less severe extent (data not shown). Thus, 
we hypothesize that mutations modulate phase separation differently in various bound-
states of UBQLN2. 
 For this study, we purified and expressed six N-terminal domain deletions (full-
length (FL), 109C, 178C, 248C, 379C, and 450C) to identify how different domains, and 
domain features, may contribute to, or modulate UBQLN2 LLPS behavior (Figure 3). 
Additionally, we introduced two representative ALS-linked mutations, T487I and P497L, 
one at a time, into full-length UBQLN2 and each domain deletion construct. We 
hypothesize that that disease-linked mutations differentially tune LLPS across these six 
domain deletion constructs. By analyzing the phase-separating behavior of domain 
deletion constructs via temperature-ramp turbidity assays and size exclusion 
chromatography, we have begun to understand how each domain differentially tunes 












Generation of UBQLN2 Domain Deletion Constructs and Mutants 
 UBQLN2 constructs were designed to successively remove each N-terminal 
domain and linker region (Figure 3A). First the full-length protein was expressed and 
purified using established protocols (Dao et al., 2018, 2019). Removal of the UBL 
domain generated the 109C construct. The UBL domain and the first linker region was 
removed with the 178C construct. Deletion of successive N-terminal domains and linker 
regions was continued up to the STI1-II region (constructs 248C and 379C) (Figure 3B). 
Construct 450C was also included in our domain-deletion library as it is the smallest 
construct of UBQLN2 that undergoes LLPS similarly to FL, (Dao et al., 2018).  All 
domain deletion constructs were subjected to brightfield microscopy under phase-
separating conditions to verify that all constructs do indeed phase separate (Figure 3C). 
All protein constructs were expressed in E. coli. We took advantage of the ability of 
each construct to phase separate with increasing salt to purify UBQLN2 from the rest of 
E. coli cell lysate (see methods) (Dao et al., 2018, 2019). No construct contains any 
affinity tag for purification. After generation of the domain deletion constructs for wild-
type UBQLN2, we introduced ALS-linked mutations, T487I and P497L, one at a time 
into each domain deletion construct via site-directed mutagenesis. The resulting 
proteins were expressed in E. coli and purified via a similar salting-out method as wild-
type since all mutated constructs phase-separated with increasing salt concentration.  





Turbidity Assays Screened for Differential Effects on UBQLN2 LLPS 
 To systematically investigate the differences in phase separation properties of 
UBQLN2 domain deletion constructs, we subjected each protein to temperature-ramp 
turbidity assays at conditions which induced phase separation. We previously adopted 
this technique to monitor LLPS of UBQLN2 450C constructs as a function of 
temperature (Chapter 2) (Yang et al., 2019). We monitored the change of absorbance 
(A600) values between 16 and 60°C of protein samples at a fixed protein concentration. 
These assays were repeated for a minimum of four times to ensure reproducibility. 
Initially, we observed two major trends—a class of constructs which significantly 
promoted phase separation in that they lowered the protein saturation concentration 
needed for LLPS, and a class of constructs which decreased phase separation in that 
they increased the saturation concentration. Because of this, we screened those which 
promoted LLPS (109C, 178C, and 379C) using a low protein concentration of 10 µM, 
and we screened those with decreased LLPS (FL, 248C, and 450C) using 50 µM 
protein (Figure 4A). However, 450C phase-separated much less in comparison to FL 
and 248C. Using 10 µM protein, 109C, 178C, and 379C were clustered together, though 
with decreasing cloud point temperatures, respectively. All constructs exhibited an 
increase in turbidity (phase separation) as temperature was raised from 16 to 45oC. 
This transition is called a LCST (lower critical solution temperature) phase transition, as 
there is a temperature below which the solution is well mixed, and above this 
temperature the protein solution is demixed, or phase-separated. Consistent with 
previous findings, as temperature is further increased from 45 to 60°C, the 450C 





critical solution temperature), as there is a critical temperature below which the solution 
is phase-separated and above which the solution is mixed and single-phase (Yang et 
al., 2019). Interestingly, 248C presents relatively diminished absorbance from 45 to 
60°C, though we do not see a return to a completely mixed solution. This indicates 
248C may also have a UCST phase transition, though it would be outside of these 
experimental conditions. This initial screen informs us that UBQLN2 domains modulate 
phase separation properties to different extents. Moreover, we can postulate that N-
terminal domains and linkers contribute to UBQLN2 multivalency to different capacities.  
 Given the differences observed across N-terminal domain deletion constructs, we 
hypothesized that mutations to these constructs would also modulate the phase-
separating properties incongruously. Disease-linked mutation P497L was introduced 
into each domain deletion construct, and subsequently purified and screened for LLPS 
in the same manner as WT constructs presented above (Figure 4B). It should be noted 
that turbidity assays for P497L mutant constructs were performed over a temperature 
range of 4-60°C since they phase-separated at lower temperatures than WT. 
Interestingly, the same group of constructs that exhibited phase separation at lower 
concentrations in WT (109C, 178C, and 379C) also exhibited phase separation at lower 
concentrations in the P497L mutant domain deletion constructs (Figure 4B). Likewise, 
the group of WT constructs that required higher concentrations for phase separation 
(FL, 248C, and 450C) also required higher concentrations with the introduction of the 
mutation. Interestingly, WT FL behaves similarly to P497L FL (Figure 4B). However, the 
introduction of P497L mutation to construct 450C resulted in phase separation at 





lower temperatures than WT 248C. Interestingly, mutation P497L to constructs 109C, 
178C and 379C results in a downward shift in the temperature which initiates phase 
separation, though the overall absorbance was diminished in each mutant construct. In 
general, the mutation P497L appears to shift phase separation initiation to a lower 
temperature in all constructs. However, this is not the case in FL. This further suggests 
that mutations have differential effects on UBQLN2 phase separation, dependent on 
which domain-deleted construct to which it is introduced.  
 
Phase Diagrams Quantitatively Describe the Effects of Domains on LLPS 
To quantitatively describe how domains and linkers alter the conditions which 
induce phase separation, and how mutations may also alter this, we experimentally 
obtained the low protein concentration arm of temperature—concentration phase 
diagrams. (The high protein concentration arm would reveal the protein concentration 
inside the protein droplets.) At a protein concentration which did not induce phase 
separation at the beginning of the experiment (4°C), I performed temperature-ramp 
turbidity assays and obtained the cloud-point temperature (Tcp) at the inflection point of 
the phase transition (Figure 5A). This was repeated using a series of four protein 
concentrations to map the phase boundary (Figure 5B). This process was repeated with 
all six WT domain deletion constructs, and was repeated a minimum of four times at 
each protein concentration to ensure reproducibility (Figure 6). With WT full-length 
UBQLN2 as a point of reference, we observed that domain deletion constructs impacted 
LLPS both positively and negatively, in terms of promoting (lowering saturation 





248C and 450C constructs do not phase separate as readily as they significantly 
increased saturation concentration necessary for LLPS. Conversely, constructs 109C, 
178C, and 379C all tend to promote UBQLN2 LLPS. From these three constructs, 109C 
and 178C behave strikingly similar within error. Construct 379C, though only 71 amino 
acids longer than 450C, shows a greatly increased propensity to phase separate, as 
this construct is observed to have the lowest saturation concentrations at all 
temperatures tested.  
Overall, domain deletion constructs do not follow a specific pattern, but rather 
suggest distinct tendencies for each construct (Figure 6). For instance, starting with the 
smallest construct, 450C, we observe the least amount of phase separation. This is 
plausible since 450C, being the shortest, has the least amount of residues available to 
partake in multivalent interactions. Moving forward, 379C shows much more phase 
separation at the temperatures and concentrations tested. Reasonably, this makes 
sense given it incorporates the second prion-rich region, and has more residues 
potentially involved in multivalency. However, 248C has far less phase separation 
tendency even though it is longer than 379C. With the addition of the first STI1-I region 
(178C), we again observe increased phase separation. Construct 109C is longer still, 
and contains the first proline rich region, though no appreciable change is observed. 
Finally, with the incorporation of the UBL domain in the FL construct, we again observe 
decreased phase separation at the conditions tested. This back-and-forth nature 
suggest that UBQLN2 domains and linkers differentially tune LLPS in a non-






Phase Diagrams Quantitatively Describe the Effects of Mutations 
To investigate how mutations alter phase separation in a domain-dependent 
manner, ALS-linked mutations P497L and T487I were introduced to UBQLN2, and 
temperature—concentration phase diagrams were obtained (Figure 6). When P497L 
was introduced into full-length UBQLN2, there was no appreciable change to the overall 
phase diagram as compared to wild-type FL UBQLN2. However, this trend did not hold 
for any of the domain deletion constructs tested here. In general, the introduction of the 
P497L mutation appears to shift the phase transition to lower protein concentrations and 
temperatures for all domain deletion constructs (Figure 6). For P497L constructs 109C, 
178C, 379C, and 450C, phase separation was drastically promoted, in that phase 
separation was observed at low temperatures even at a low concentration of 5 µM. 
P497L 248C was particularly interesting in that the shape of the phase boundary 
remained generally the same between mutant and WT, but the phase transition was 
observed at lower temperatures for P497L, shifting its phase diagram in a downward 
manner.  
Previous data produced by the lab indicated that disease-linked mutation T487I 
drastically altered phase-separating properties for the 450C domain deletion construct 
(Dao et al., 2019). We introduced this mutation into domain deletion constructs 109C, 
178C, 248C, 379C, and 450C. In accordance with data presented above, constructs 
109C, 178C, and 379C exhibited a significantly large downward shift in saturation 
concentrations (data not shown). Because of this, it was not experimentally feasible to 
acquire reproducible temperature—concentration turbidity data at such low 





saturation concentrations to different degrees (Figure 6). In 248C we observed a mild 
downward shift of the phase boundary. Interestingly, the phase boundaries for both the 
T487I and P497L mutations overlap at some protein concentrations (Figure 6). Based 
on these conditions, we can broadly say that mutations T487I and P497L affect 248C 
phase separation in a similar manner. However, mutation T487I drastically shifts 450C 
phase diagram when compared to both WT and P497L (Figure 6). The T487I mutation 
in the 450C background shifts the saturation concentrations to 5-15 µM, with cloud point 
temperatures between 15 and 20°C, a significant shift from WT and P497L 450C. 
 
Size Exclusion Chromatography Describes UBQLN2 Self-Association 
 Under non-phase-separating conditions, we probed UBQLN2 domain deletion 
constructs for self-association since oligomerization is a prerequisite for UBQLN2 LLPS 
(Dao et al., 2018). All purified WT constructs were subjected to size exclusion 
chromatography (SEC) in increasing protein concentrations (10 and 100 µM) over an 
Enrich SEC 650 10 X 200 column (Biorad). The lab previously confirmed that WT 450C 
UBQLN2 is monomeric at low concentrations (10 µM and 100 µM) but forms large 
oligomers at higher concentrations (500 µM), consistent with concentration-dependent 
oligomerization. As expected, FL and all five domain deletion constructs exhibited a 
decrease in elution volume with increasing protein concentration from 10 to 100 µM 
(Figure 7). Interestingly, most constructs (109C, 379C and 450C) appear to elute in a 
similar trend as WT FL UBQLN2, based on their relative differences in size. However, 
constructs 178C and 248C have a population of large species which elutes around 9 





whereas 248C also shows the presence of mixed oligomeric species at the 9 mL elution 
volume peak. Notably, the 248C construct exhibits a broad peak at 12 mL, indicative of 
numerous oligomeric species.  
 
Discussion 
 Elucidating the role that each domain plays in UBQLN2 phase separation is 
critical to understanding how UBQLN2 behaves in cells and how phase separation 
contributes to UBQLN2 function in vivo. In these studies, we have demonstrated how 
domains contribute differently to UBQLN2 phase separation. We postulate that various 
domain deletion constructs mimic different bound states of UBQLN2. For instance, the 
109C construct, which does not contain the UBL domain, may mimic the state which 
UBQLN2 is engaged with the proteasomal receptors Rpn10 or Rpn13 (Chen et al., 
2016). The 248C, 379C, and 450C constructs could all possibly mimic the association of 
UBQLN2 with a client protein via the STI1-I or STI1-II domains. While the in vitro data 
herein cannot predict the precise behavior of UBQLN2 when introduced to the cellular 
milleu, we suggest that bound states of UBQLN2 may alter the available multivalent 
interactions for phase separation, which therefore likely tunes UBQLN2 behavior in 
cells.   
Recent literature describes phase-separating proteins as containing stickers, 
regions which drive LLPS via interchain interactions, and spacers, those sequences 
which connect stickers and can modulate LLPS in a manner that exposes stickers, or 
conceals stickers (Martin et al., 2020). Similarly, the field has adopted terms like primary 





those which largely contribute to LLPS, and those which modulate LLPS properties, 
respectively (Bratek-Skicki et al., 2020). The data herein begin to uncover which 
domains of UBQN2 may act more as stickers, and those which may be spacers. We 
have observed trends which lead us to several general conclusions.   
Based on these data, we hypothesize that the structured UBL domain may modulate 
UBQLN2 LLPS in a way that hinders the formation of multivalent contacts. The 109C 
construct, which deletes only the UBL domain, exhibits enhanced phase separation in 
comparison to FL at the same concentration and temperature, regardless of whether the 
protein is WT or mutated (Figure 6). Therefore, it is sensible to suggest that the 
structured UBL domain may sterically hinder the formation of intra- and intermolecular 
contacts which drive LLPS. Supporting this, the 178C construct also presents a similar 
phase-separating profile as 109C, which is sensible considering 109C and 178C only 
differ by the linker region between the UBL and STI1-I regions (Figure 6). With this 
theory in mind, it is plausible that UBQLN2 has a greater phase-separating propensity 
as it contacts the proteasome via its UBL domain in the cell. 
The 109C and 178C constructs both present increased phase separation when 
compared to FL UBQLN2. This informs us that the UBL domain may modulate LLPS 
such that it diminishes multivalent contacts resulting in a reduced propensity to phase 
separate. This may stem from UBL interactions with other parts of the UBQLN2 
sequence. However, the linker between UBL and STI1-I domains (residues 109-177) 
does not significantly change LLPS behavior, indicating that this region may minimally 
tune phase separation. In contrast to this idea, SEC results reveal that the 178C 





degree of phase separation (Yang et al., 2019). Additionally, the predicted prion-like 
sequence between residues 100-150 would suggest this linker as a site of self-
association (Figure 1B). However, this prediction was not supported by SEC data, nor 
did the region appear to significantly alter phase behavior between constructs 109C and 
178C (Figure 6 and 7). Alternatively, SEC data could be corroborated in that UBQLN2 
oligomerization is mainly dependent upon the STI1-II region, which is present in all 
constructs except 450C (Dao et al., 2018; Ford and Monteiro, 2006; Kurlawala et al., 
2017) 
Similarly, the linker region between the two STI1 domains appears to hinder LLPS to 
a degree. This is shown by the vast difference in phase-separating profiles of the 248C 
and 379C constructs. We hypothesize that the enhanced phase-separating behavior of 
construct 379C could be linked to the full exposure of the predicted prion-like sequence 
between residues 350 and 450 in the STI1-II domain (Figure 1). Supporting this, NMR 
studies have previously identified the STI1-II as a domain contributing to UBQLN2 self-
association (Dao et al., 2018). Thus, it is reasonable to suggest that the 248-378 linker 
region blocks interaction contacts at the prion-like STI1-II domain.  
In these experiments, we have also introduced mutations T487I and P497L. 
Generally, mutation T487I induced higher phase separation tendencies to all 
constructs—so much so that phase diagrams could not experimentally be constructed 
for T487I 109C, 178C, and 379C. Interestingly, in constructs 248C and 450C, mutation 
T487I tuned LLPS to very different degrees. In 450C we observe an enormous 
increased in phase separation, indicated by decreased cloud point temperature at 





however to a much lesser degree than what is observed in 450C. The difference in 
effect of this mutation suggests that mutations alter phase behavior via a different 
mechanism in different constructs. Similarly, mutation P497L also induced higher phase 
separation tendency, though this was also seen to different extents in different 
constructs. Therefore, we can insinuate that in cells, disease-linked mutations may alter 
phase behavior differently, dependent on the binding state of UBQLN2.  
We also must consider that domain deletion constructs vary in size and shape, and 
consequently may not be directly comparable. By successively deleting N-terminal 
domains, UBQLN2 obviously becomes smaller in size, and also likely changes the 
three-dimensional shape for the remaining part of the construct. A conformational 
change of shape to UBQLN2 may expose or conceal sites of multivalent interactions, or 
stickers. For instance, if the UBL domain interacts with the UBA domain on the C-
terminal end of UBQLN2, the protein could fold over the inner domains, sterically 
hindering the inner domains from making multivalent contacts. In this case, the 
construct deleting the UBL would expose this section, resulting in more multivalent 
contacts, and thus a higher propensity for phase separation. Additionally, successive 
deletion of domains and linkers removes residues involved in multivalency. With this 
rationale, longer constructs have more residues partaking in multivalent contacts, where 
shorter constructs have fewer residues involved in contact. 
 These data suggest that UBQLN2 domains modulate LLPS differentially, though 
additional investigation is warranted to fully elucidate how these domains, and their 
respective characteristics contribute to LLPS as a whole. Importantly, these data can be 





between STI1- domains may hinder UBQLN2 LLPS. Additionally, we can predict that 
the prion-like region in the STI1-II domain is a main site of multivalent interactions, and 
thus drives UBQLN2 LLPS. Importantly, these data further confirm that liquid-liquid 



























Figure 1. Structure and Function of UBQLN2. (A) Domain architecture and 
associations of UBQLN2. (B) Sequence-based disorder, prion-like predictions, and P-
score predictions of UBQLN2. Disorder probability was calculated using PONDR-FIT, 
Pondr-VLXT, and Disprot-VL3H, where the average of the three is shown in black (Li et 
al., 1999; Obradovic et al., 2003; Romero et al., 1997; Xue et al., 2010). Prion-like 
probability was calculated using PLAAC, and identified prion-like regions are highlighted 
in yellow on the domain map (Lancaster et al., 2014). P-score values predict phase 
separation propensity, and were calculated using Phase Separation Predictor (Vernon 
et al., 2018). (C) Disordered (gray), prion (yellow), and positive P-score (orange) 








Figure 2. Disease-linked mutant phase separation properties are different in 
UBQLN2 450C and FL. Protein concentration for 450C is 50 µM and FL is 20 µM. 







Figure 3. Domain Deletion constructs of UBQLN2. (A) N-terminally domain deleted 
constructs. (B) Purified UBQLN2 protein samples on SDS-PAGE gel are loaded as: 1: 
450C, 2: 379C, 3: 248C, 4: 178C, 5: 109C, 6: FL. Molecular weight markers are labeled 
on the left side in kDa. (C) Brightfield microscopy imaging of UBQLN2 domain deletion 
constructs. Protein concentration is 50 µM for FL, 109C, 178C, and 379C, and 200 µM 
for 248C and 175 µM for 450C. Protein is in 200 mM NaCl, 20 mM Hepes pH7 buffer, at 
30oC after 10 minutes. Microscopy images are from Thuy Dao.   
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Figure 4. Turbidity assays screen for LLPS in WT and P497L domain deletion 
constructs. (A) Spectrophotometric turbidity assay results for WT UBQLN2 domain 
deletion constructs at 50 µM (FL, 248C, 450C) and 10 µM (109C, 178C, 379C) in 20 
mM NaPhosphate and 200 mM NaCl (pH 6.8). (B) Spectrophotometric turbidity assay 
results from mutant P497L UBQLN2 domain deletion constructs at 50 µM (FL, 248C, 
and 450C) and 10 µM (109C, 178C, 379C) in 20 mM NaPhosphate and 200 mM NaCl 
(pH 6.8). Darkness of the square correlates with cloudiness of the solution, such that 











Figure 5. Phase diagrams map conditions of phase separation. (A) Temperature—
ramp spectroscopic data is fit to a Four Parameter Logistic Regression model to 
determine the cloud point temperature (Tcp) at the inflection point of the transition at 
each concentration (in µM). (B) The phase boundary (dotted) is mapped, where the 
colored dots represent the experimental cloud point temperatures obtained. UBQLN2 
samples above the phase boundary are in the phase-separated state, whereas samples 







          
 
 































































Figure 6. Temperature-concentration phase diagrams for domain deletion 
constructs of wild-type and mutant UBQLN2. (A) Phase diagrams for full-length and 
domain deletion constructs of wild-type UBQLN2 and disease-linked P497L and T487I 
mutants. (B) Phase diagrams as in panel A, except they are organized according to 
domain deletion construct. Experimental cloud point temperatures are plotted which 
map the LLPS phase boundary, and the lines connecting points are guides to visualize 
the low-concentration arm of the phase boundary. Domain deletion constructs are color-
coded (black: full-length (FL), etc.) Error bars represent standard deviation of cloud 
point temperatures using n=4 trials from two separate protein purifications, with the 
























































































































































































exception of P497L 379C and P497L 450C, which both had n=2 trials from one protein 














Figure 7. Oligomerization propensity of UBQLN2 domain deletion constructs. Size 
exclusion chromatography (SEC) profiles of (A) FL, 109C, and 178C and (B) FL, 248C, 
379C, and 450C domain deletion constructs. The thinnest lines represent protein 
concentration of 10 µM, and the thickest lines represents 100 µM. Plots were divided by 
those constructs with higher molecular weights and lower molecular weights, where FL 
was plotted in black on both plots for visual comparison. Proteins were in pH 6.8 buffer 






















Subcloning, Protein Expression, and Purification 
UBQLN2 mutants were generated from UBQLN2 using Phusion Site-Directed 
Mutagenesis Kit (Thermo Scientific). A tryptophan codon was added to the C-terminal 
end of all constructs to facilitate determination of protein concentration. UBQLN2 
constructs and all mutants were expressed and purified as described in (Dao et al., 
2018). Briefly, the constructs were expressed in E. coli Rosetta 2 (DE3) pLysS cells in 
Luria-Bertani (LB) broth at 37°C overnight. Bacteria were pelleted, frozen, lysed, then 
purified via a “salting out” process. NaCl was added to the cleared lysate to the final 
concentration of 0.1 M - 1 M. UBQLN2 droplets were pelleted and then resuspended in 
20 mM NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3 (pH 6.8). Leftover 
NaCl was removed through HiTrap desalting column (GE Healthcare). SDS-PAGE gels 
were performed to confirm the purity of the proteins. Purified proteins were frozen at 
−80°C. 
 
Spectrophotometric Absorbance/Turbidity Measurements 
Protein samples were prepared by adding protein (from stock to a final concentration 
noted for each experiment) to cold sodium phosphate buffer (pH 6.8, 20 mM 
NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3) containing 200 mM NaCl 
and were kept on ice before the assay. Absorbance at 600 nm was recorded as a 
function of temperature by an Agilent Cary 3500 UV-visible (UV-Vis) spectrophotometer 
using a temperature ramp rate of 1°C/min increasing from 16°C or 4°C to 60°C. Net 





control. Results were averaged from data collected using proteins from at least two 
separate preps and two trials for each (total n ≥ 4) for most constructs. Data were 
plotted using Mathematica (Wolfram Research). 
 
Phase diagram measurements 
For the LCST (lower critical solution temperature) phase transition, i.e. mapping the 
phase boundary as temperature is increased, protein samples were prepared as 
described for the turbidity measurements. Absorbance at 600 nm was recorded as a 
function of temperature by a Beckman DU-640 UV/Vis spectrophotometer using a 
temperature ramp rate of 1°C/min increasing from 4°C to 60°C. Four trials (n = 4) were 
conducted using three to five different concentrations of wild-type and mutant UBQLN2 
protein constructs for each arm. The protein concentrations were chosen to cover as 
wide a range as possible to allow observation of phase separation during the 
temperature ramps but not at the starting temperature of 4°C. Cloud point temperatures 
were determined by fitting a Four Parameter Logistic Regression model to the data. 
 $ = & +	 ()*
+,-./0
1  (Equation 1) 
Cloud point temperatures used were the point of inflection (c). Cloud point temperatures 
were then used to define the coexistence curve as a function of protein concentration. 









Size Exclusion Chromatography 
Purified UBQLN2 constructs at different concentrations (10 μM and 100 μM) were 
subjected to chromatography over a ENrichTM SEC 650 10 x 300 column (Biorad) on a 
Biorad NGC system. Experiments were conducted using 300 μL of protein at ambient 
temperature using 1 mL/min flow rate in pH 6.8 buffer containing 20 mM NaPhosphate, 
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A principle advantage of membraneless organelles (MLOs), which form via liquid-liquid 
phase separation (LLPS), is that they rapidly and dynamically respond to cellular and 
environmental cues. In response to biological signals, MLOs can assemble, 
disassemble, and change their own material properties, for example. The dynamic 
nature of MLOs requires that they have regulatory mechanisms to condense and 
dissipate upon response. Post-translational modifications (PTMs) have emerged as one 
of these regulators. PTMs are common in physiological environments, and previous 
work has shown that PTMs play a large role in LLPS regulation in vivo. Recent studies 
using glutamic acid mutations to UBQLN2 as a phosphomimetic illustrate that PTMs 
have the ability to alter UBQLN2 LLPS properties. A disadvantage of bacterial 
expression of UBQLN2 is that bacteria do not possess machinery to install PTMs. Here, 
I propose experimental methods to examine PTMs in UBQLN2 by recombinantly 
expressing and purifying UBQLN2 from eukaryotic Sf9 insect cells. Insect cells contain 
machinery to add ‘mammalian-like’ PTMs. Through in vitro studies of post-translationally 
modified UBQLN2, we can determine if UBQLN2 is modified by PTMs, how PTMs may 











Membraneless organelles are distinct from their membrane-bound counterparts 
in that they can readily form and dissolve within the cytoplasm in response to 
environmental signals (Bah and Forman-Kay, 2016). MLO components regulate their 
inter- and intramolecular contacts such that these recruited molecules either condense, 
or dissipate into the cytoplasm. Certain physiological mechanisms must be responsible 
for varying the concentration at which the proteins or other macromolecules phase 
separate in order to regulate controlled dissolution and condensation of MLO 
components. Though the regulation of MLO formation and dissolution is widely 
unknown, groups have begun to discover what types of cellular mechanisms may be 
responsible for the reversible nature of MLOs.  
Early on, Brangwynne and colleagues described P granules in germline cells of 
Caenorhabditis elegans as controlled liquid droplets. They found that these P granules 
localize via a physicochemical mechanism controlled by the dispersion of polarity 
proteins (Brangwynne et al., 2009). Another MLO commonly studied, the stress granule, 
rapidly assembles upon the presentation of cellular stress (Dao et al., 2018). Many of 
the proteins found inside stress granules also undergo LLPS. Significant knowledge of 
ribonucleoprotein granule regulation has been discovered through the study of the 
protein FUS, a phase-separating protein driven by its intrinsically disordered low-
complexity (LC) domain. Cell studies have shown that FUS granule condensation can 
be regulated by manipulating the number of arginine and tyrosine residues within the 
protein (Wang et al., 2018). Furthermore, post-translational arginine methylation 





groups on arginine promotes condensation (Qamar et al., 2018). Dissolution of FUS 
granules was found to be modulated by transportin, a molecular chaperone (Qamar et 
al., 2018). 
As mentioned above with arginine methylation, PTMs have emerged as a major 
regulator of condensates. Since PTMs of specific amino acids modify physicochemical 
properties of proteins by altering charge, bulkiness, and sterics, it is not surprising that 
they are an important regulator of LLPS (Bah and Forman-Kay, 2016). Therefore, 
modifications to key phase-separating proteins have the ability to modulate the 
condensation and dissolution of cellular MLOs. Several groups have studied how 
phase-separating proteins are modified, and have analyzed how these modifications 
alter their phase-separating properties and their recruitment into MLOs. Phosphorylation 
of serine-rich IDPs has been shown to regulate RNA granules (Wang et al., 2014). 
Additionally, the Bonini lab has shown that the addition of ADP-ribose to the protein 
TDP-43 instigates recruitment of the protein into stress granules, while phosphorylation 
of TDP-43 is required for TDP-43 recruitment into cytoplasmic inclusions and leads to 
neurodegeneration (McGurk et al., 2018). Even studies which investigate phase 
separation in vitro have exposed PTMs as modulators of LLPS properties (Ferreon et 
al., 2018; Li et al., 2012). 
Interestingly, UBQLN2 possesses nine disease-linked mutations which reside within 
its unique proline-rich (PXX) region (Dao et al., 2019; Deng et al., 2011). These 
mutations have been shown to cause dominant X-linked inheritance of amyotrophic 
lateral sclerosis (ALS) and ALS/dementia, and facilitate the formation of cytoplasmic 





2015). Of these nine PXX mutations, six are mutated to either a serine, or threonine, 
both of which are residues which can be phosphorylated. These features make the 
UBQLN2 PXX region and phosphorylation interesting avenues for investigation of 
UBQLN2 regulation via PTMs. Notably, mass spectrometry (MS) experiments do not 
find that the PXX region is PTM-modified. However, this is largely due to the fact that 
UBQLN2 cannot be digested in typical ways for PTM analysis, as trypsin is typically 
used as a protease which cleaves at lysine and arginine residues, and the PXX region 
does not contain lysine or arginine residues. 
In an effort to recapitulate the effect of phosphorylation on UBQLN2 properties, we 
have used glutamic acid substitutions as phosphomimetic substitutions for preliminary 
studies on the effect of PTMs on UBQLN2 phase separation. Because glutamic acid 
mutations introduce a negative charge much like a phosphate group, researchers have 
used Glu residues to introduce phosphomimetic modifications to phase-separating 
proteins (Wang et al., 2018). In a recent study, glutamic acid mutations at positions 
P497, P506, P525, V538, and V564, incorporating both “sticker” and “spacer” positions 
and three positions within the PXX region, were expressed and purified via site directed 
mutagenesis in the UBQLN2 C-terminal construct, 450C (Chapter 2). The resulting 
protein was screened for LLPS with temperature ramp turbidity assays. Strikingly, all 
glutamic acid mutations show extremely diminished phase separation in comparison 
with WT 450C UBQLN2 (Figure 1A). It is interesting to note that the phosphomimetic 
mutation resulted in diminished phase separation at both sticker (P497, P506, and 
V564) and spacer (P525 and V538) positions. Self-association of phosphomimetic 





UBQLN2 LLPS (Dao et al., 2018). However, SEC revealed little difference between WT 
UBQLN2 and glutamic acid mutants, with the exception of P525E, where a small 
population eluted near void volume (Figure 1B). Additionally, phosphomimetic protein 
was subjected to analysis via microscopy, which largely showed disperse, micron-sized 
‘granules’, rather than spherical fusing droplets which appears after 10 minutes in WT 
UBQLN2 (Figure 2). Mutant V538E formed phase-separated droplets after 30 minutes, 
and mutant P525E formed large aggregates after 30 minutes. Though these preliminary 
studies were not conducted in the full-length protein, it portrays the ability of a 
phosphomimetic substitution to significantly alter phase-separating behavior. 
As PTMs have emerged as important modulators of LLPS, and as preliminary 
studies have shown that phosphorylation has the capacity to significantly alter LLPS, it 
is important that studies on UBQLN2 phase separation include native PTMs. Pioneers 
in the field, Alberti and Hyman, have suggested that phase separation assays be 
performed with protein expressed from insect cells, which ensures that they receive 
PTMs (Alberti et al., 2018). Studying the effect of native PTMs on UBQLN2 phase 
separation in vitro could give insight into how PTMs regulate condensation, dissolution, 
or material properties of UBQLN2-containing condensates in vivo. With this in mind, it is 
also important to note that UBQLN2 features intrinsically disordered regions (IDRs) 
which are regions often modified with PTMs (Hofweber and Dormann, 2019). 
Databases also suggest sites for modification via phosphorylation, ubiquitylation, and 
acetylation (Hornbeck et al., 2015). 
Here, I describe the novel expression and purification of full length UBQLN2 in 





system. Baculoviral expression in Sf9 cells was chosen because: 1) proteins receive the 
post-translational modifications that are required for normal protein activity and 
behavior, 2) recombinant proteins are processed, modified, and targeted to their 
appropriate cellular location in insect cells, which makes them functionally similar to 
their authentic counterparts, 3) genes are abundantly transcribed during late stages of 
infection, as opposed to other eukaryotic expression systems  and  4) the insect cell 
expression system is safe in that baculoviruses have limited host range, specific to 
invertebrates (Invitrogen, 2015). 
 
Results 
 The methods presented below provide a proof of principle that full length 
UBQLN2 can be expressed and purified from Sf9 insect cells. In overview, UBQLN2 is 
first cloned into pFastBacDual + RFP (red fluorescent protein), the donor plasmid. This 
plasmid is transformed and transposed into DH10Bac cells, and the resulting 
recombinant bacmid DNA is used to transfect Hi5 cells for the production of passage 1 
(P1) baculovirus. P1 virus is used to infect Sf9 cells for passage 2 (P2) baculoviral 
production. Finally, P2 baculovirus infects Sf9 cells for expression, and later purification. 
 
Generation of UBQLN2 baculovirus 
UBQLN2 baculoviral stock was generated using the Bac-to-Bac Baculoviral 
Expression System and the pFastBac Dual plasmid containing UBQLN2 under the 
control of the polyhedron promoter and RFP under the p10 promoter. RFP is used here 





expression. Baculovirus stocks were prepared according to the manufacturer’s protocol, 
and slightly adapted to the Hougland lab protocol (Figure 3) (Invitrogen, 2015; Sieburg 
et al., 2019). 
pFastBacDual plasmid was supplied by the manufacturer, and RFP was cloned 
under the p10 promoter by the Hougland lab. PCR-amplified UBQLN2 was cloned into 
this plasmid downstream of the polyhedron promoter and transformed into DH5alpha 
cells. These cells were grown overnight on selection plates; single colonies were 
miniprepped from overnight liquid cultures, and the DNA was eluted in water (Figure 4). 
pFBD p10RFP UBQLN2 was then transformed into DH10BacTM E. coli cells, and plated 
on Bac plates, which are prepared with kanamycin, gentamycin, tetracycline, Bluo-gal, 
and IPTG. UBQLN2 transposition was confirmed with a x-gal blue-white screen, PCR 
amplification of the transposed region using pUCM13 rev/for primers, and gel 
electrophoresis (Figure 5). DH10BacTM competent cells were used for bacmid extraction 
and amplification. Bacmid DNA was used for transfection of Hi5 cells (Passage 1; P1). 
Hi5 cells were used for P1 because they have a very good viral yield, and adhere better 
to a flask than our stock of Sf9 cells. When cells were ~80% lysed, and media was 
visibly pink, Passage 1 UBQLN2 baculoviral stock was collected. Passage 1 UBQLN2 
baculoviral stock was used for the infection of Sf9 cells for the generation of Passage 2 
UBQLN2 baculovirus, which is necessary for the virus to be in the same media as the 
final expression. When the Sf9 cells were ~80% lysed, and media was visibly pink, P2 
UBQLN2 baculoviral stock was harvested and stored for the infection of Sf9 cells for 






Sf9 cell preparation and infection 
 Sf9 cells were propagated and grown in Sf900-III medium at 28oC with shaking at 
140rpm. This expression culture was inoculated with P2 UBQLN2 baculovirus particles. 
UBQLN2 was expressed for 48 hours at 28oC with shaking (140 rpm). A western blot 
confirmed UBQLN2 expression, though the blot appeared to be overloaded (Figure 6A). 
For visual comparison, a western blot of various volumes of purified UBQLN2 is 
included (Figure 6B). The expression culture was harvested, and the cells were pelleted 
via centrifugation at 500 x g for 5 minutes at room temperature. The supernatant, which 
contained UBQLN2 as the cells were lysed, was aspirated from the pink-colored pellet, 
which was stored at -80°C until purification.  
 
Purification of UBQLN2 
Cells were lysed and purified via a “salting out” process. NaCl was added to the lysate 
to a final concentration of 1M, which produced UBQLN2 droplets in solution. UBQLN2 
droplets were pelleted and then resuspended in 20 mM NaPhosphate, 0.5 mM EDTA 
(pH 6.8). Leftover salt was removed through a HiTrap desalting column (GE 
Healthcare). A SDS-PAGE gel was performed to confirm the identity and purity of 
UBQLN2 (Figure 7). These experiments indicate that full-length UBQLN2 was 
expressed and purified from insect cells. 
 
Conclusions and Future Studies 
Eukaryotic expression of UBQLN2 will begin the development of a more 





UBQLN2. The work presented in this chapter is a proof of principle study to show that 
we can express and purify full-length UBQLN2 from insect cells. Further experiments 
are required to examine the PTM state of UBQLN2 (discussed below). The expression 
system discussed herein will permit us to determine the effect of PTMs on its phase-
separating behavior. These studies have the potential to direct future in vivo 
investigation of PTMs on the ability of UBQLN2 to form stress-induced condensates in 
the cell as well as examine how UBQLN2 recruitment to stress granules affect stress 
granule condensation and dissipation.  
Initially, as a screen for post-translational modification, the molecular weight of 
purified UBQLN2 would be analyzed via mass spectroscopy. In an effort to identify sites 
and types of modification, chymoptrypsin and glutamyl peptidase can be used to cut 
UBQLN2 in optimal pieces for proteomics. These proteases were chosen because their 
specificity for the hydrolysis of peptide bonds at tryptophan, tyrosine, phenylalanine, or 
leucine. By cutting the sequence at these residues, the resulting fragments are small 
enough for a residue-by-residue analysis. High resolution mass spectroscopy can be 
used to localize sites and identify types of post-translational modification. It is important 
to note that eukaryotic-expressed UBQLN2 may result in populations of mixed 
modification, or populations of unmodified UBQLN2. Hypothesized from UBQLN2 
phosphomimetic data, some modified protein may not phase separate, which would 
require a different method of purification, since our existing purification method is 
dependent on the ability of UBQLN2 to phase separate. In this case, an affinity tag (e.g. 





Post-translationally modified UBQLN2 may then be investigated via in vitro 
biochemical and biophysical techniques utilized in the Castañeda lab including 
structural studies via NMR, temperature—concentration phase diagram analysis, self-
association analysis via SEC, and droplet properties via microscopy. By comparing 
these results to those from unmodified UBQLN2, we can tease out what effect PTMs 
have on UBQLN2 LLPS in vitro. As we have shown that UBQLN2 LLPS is modulated in 
an amino acid-dependent manner, we hypothesize that the addition of a PTM would 
also vary LLPS phase behavior and droplet properties.  
Importantly, the data from these experiments could inform how PTMs may 
regulate MLO condensation and dissolution. For instance, if insect cell expression 
resulted in a population of hyperphosphorylated UBQLN2, which showed severely 
diminished phase-separating properties, we could hypothesize that phosphorylation of 
UBQLN2 could be a mechanism for UBQLN2 to exit stress granules or regulate the 
dissolution of stress granules. We then could propose future in vivo studies to test this 
hypothesis. Based on the outcomes of experiments performed on modified UBQLN2, 
we can better direct our in vitro experiments to assess the role of PTMs. Future 
investigation of UBQLN2 post-translational modification would focus on its function in 
MLO condensation/dissolution regulation and its effects on the physical properties of 
stress granules. Investigation of PTM-modified UBQLN2 and its implications in disease-
linked aberrant phase transition is of specific interest as many ALS-linked mutations 
result in residues which can be phosphorylated. Notably, these mutations have been 
shown to disrupt LLPS by facilitating a liquid-to-solid transition, and the formation of 





et al., 2015; Patel et al., 2015). These observations suggest that disease mutations alter 
LLPS properties of MLOs, and PTMs may be a worthwhile mechanism to investigate 




































Figure 1. Effects of phosphomimetic substitutions on UBQLN2 LLPS and self-
association. (A) Turbidity assays screen for phase separation in UBQLN2 mutants with 
phosphomimetic substitutions. Results from spectrophotometric turbidity assay as a 
function of temperature comparing LLPS of UBQLN2 mutants using 50 μM protein in 20 
mM NaPhosphate and 200 mM NaCl (pH 6.8). (B) Oligomerization propensities of 
phosphomimic UBQLN2 mutants (red). Representative SEC profiles of UBQLN2 
mutants at 10 μM (thinnest line), 100 μM (medium-thick), and 500 μM (thickest) protein 
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Figure 2. Brightfield microscopy of WT and UBQLN2 mutants with 
phosphomimetic substitutions. Samples were collected at 10 and 30 min at 37 °C 





















Figure 3. Schematic of the generation of recombinant baculovirus and gene 
expression adapted from Bac-to-Bac Expression System (Invitrogen, 2015). 
UBQLN2 is cloned into pFastBacDual (pFBD) + RFP (red fluorescent protein) donor 
plasmid, and the recombinant plasmid is transformed into DH10Bac E. coli competent 
cells which contain the bacmid with a mini-attTn7 target site and the helper plasmid. 
The mini-Tn7 element on the pFastBacTM donor plasmid can transpose to the mini-
attTn7 target site on the bacmid in the presence of transposition proteins provided by 
the helper plasmid. Colonies containing recombinant bacmids are identified by 
disruption of the lacZα gene. High molecular weight mini-prep DNA is prepared from 
selected E. coli clones containing the recombinant bacmid, and this DNA is then used to 
transfect hi5 cells. Once these cells lyse (represented by circles with dashed-line) the 
passage 1 virus is collected (star shaped particles). Passage 1 virus is used to infect 
Sf9 cells. Once the Sf9 cells lyse, passage 2 virus is collected and used to infect Sf9 







Figure 4. Preparation of pFastBacDual plasmid with UBQLN2 and RFP. (A) PCR 
product confirms successful production of recombinant donor plasmid pFastBacDual 
with UBQLN2 and RFP at 2 KB (product labeled in red). Lanes: 1) digested pFBD 
p10RFP; 2) ladder; 3) PCR product. (B) DNA miniprep confirms successful molecular 
cloning of UBQLN2 into pFBD + RFP. Lanes: 1) ladder; 2) undigested DNA; 3) DNA 
















Figure 5. SDS-PAGE confirms successful transposition of UBQLN2 into bacmid 
DNA using pUCM13 for/rev primers. Lanes 2-6 show PCR product of bacmid 
transposed with pFastBacDual with UBQLN2 + RFP (~ 4560 base pairs). Lanes: 1) 
ladder; 2-6) individual DH10BacTM E. coli cell colonies with UBQLN2 bacmid DNA.  
 
  













Figure 6. Western blot confirms expression of UBQLN2. (A) Mouse-Anti Ubiquilin2 
western blot of UBQLN2 expression time points. Lanes are outlined in blue and are 
loaded as: 1) 0 hrs; 2) 24 hrs; 3) 48 hrs; 4) 72 hrs; 5) 96 hrs post baculoviral infection. 
(B) Western blot of full-length UBQLN2 at various loading volumes for visual 
comparison of overloaded UBQLN2. Lanes were loaded with 1) 10 ng; 2) 20 ng; 3) 50 












Figure 7. Purification of UBQLN2 from Sf9 cells. SDS-PAGE gel lanes were loaded 
as: 1) total protein; 2) post-salt supernatant 1; 3) post-salt supernatant 2; 4) elution 1; 
















































Regarding the molecular underpinnings of UBQLN2 LLPS, the research provided 
herein identifies several driving mechanisms which largely contribute to the ability of 
UBQLN2 to phase separate. Our research on C-terminal construct, 450C, corroborates 
the “sticker” and “spacer” framework, which predicts that “stickers” are sequences which 
drive interchain interactions and phase separation, where “spacers” are sequences 
separating stickers which modulate phase separation properties by either enabling or 
suppressing contact between stickers (Chapter 2) (Yang et al., 2019). Within these 
stickers, we have shown that LLPS can be modulated by single amino acid 
substitutions, and that UBQLN2 LLPS follows a molecular code. For instance, mutations 
to hydrophobic amino acids and polar amino acids decreased cloud point temperatures, 
seemingly promoting LLPS at lower temperatures and lower concentrations. Therefore, 
the hydrophobic effect and polar interactions likely are the driving forces underlying 
UBQLN2 phase separation. This idea is also supported in that more than 25% of the 
UBQLN2 450C sequence consists of polar residues, and almost 50% of the construct 
consists of hydrophobic residues. In contrast, mutations to acidic mutations resulted in 
diminished phase separation. As acidic mutations introduce negative charges much like 
phosphorylation, and glutamic acid mutations have classically been used as 
phosphomimetic substitutions, this highlights the potential for regulation of LLPS via 
post-translational modifications, and highlighting the importance of electrostatics in 
phase-separating systems.  
 We have also initiated investigation of the specific role of UBQLN2 domains in its 





of six successive N-terminal domain deletion UBQLN2 constructs, we have discovered 
that each domain, does indeed tune phase separation differently. Interestingly, our data 
corroborate evidence that prion-like regions contributes to phase separation. However, 
in the case of UBQLN2, deletion of prion-like domains did not significantly alter self-
association behavior as expected, since prion regions have been shown to act as sites 
of oligomerization. This project helped identify how sequence features such as disorder, 
structure, and prion-like propensity may govern UBQLN2 LLPS. 
 Additionally, in chapter 4, I have proposed a method of UBQLN2 purification via 
insect cell expression, which would include the incorporation of native post-translational 
modifications (PTMs). Insect cells were chosen for expression because they possess 
the eukaryotic machinery necessary to modify recombinant proteins in a functionally 
similar way as their authentic counterparts. A baculoviral expression system was 
chosen because it ensures a high level of transcription and is safe in that baculoviruses 
have a host range limited to invertebrates (Invitrogen, 2015). PTMs are an important 
factor to consider when studying LLPS because several studies have demonstrated that 
PTMs regulate phase separation, and that many phase-separating proteins are 
modified. Here, I have described successful expression of full length UBQLN2 in Sf9 
insect cells, which provides various avenues for future research.  
 Furthermore, investigation of UBQLN2 in a domain-by-domain manner indicates 
the importance of studying full-length protein in phase separation studies. Currently in 
the field, it is common to perform experiments on smaller protein constructs due to ease 
of protein purification, and the ability to do certain in vitro analyses on smaller proteins, 





suggested that each segment of UBQLN2 plays a direct role in driving or modulating 
LLPS, it would be most physiologically significant to study phase-separating behavior of 
full-length protein.  
 
Future Directions 
 In the previous chapters, I have discussed the role of mutations and domain-
deletions on UBQLN2 LLPS, with the overarching goal to elucidate the molecular 
mechanisms which drive UBQLN2 phase separation in vitro. Here, I propose methods 
and potential directions to further investigate UBQLN2 LLPS in terms of analytical 
modeling, its behavior in cells, and its role in neurodegenerative pathology.  
The experimental data contributed here provides a benchmark for future 
analytical modeling and/or molecular simulation. By obtaining experimental phase 
diagrams, we determined that UBQLN2 exhibits LCST (lower critical solution 
temperature) phase transitions. With our experimental data, we can provide a basis for 
which simulations can reproduce sequence-specific LCST behavior. Ultimately, these 
data would provide key input for machine-learning algorithms to model phase behavior 
(Ruff et al., 2018). In addition to predicting phase behavior, an interesting application of 
these data is to the design of thermoresponsive biopolymers. Thermoresponsive 
polymer design is of recent interest due to their application in cell sheet fabrication, drug 
delivery, and 3D-printing (Suntornnond et al., 2017; Ward and Georgiou, 2011).  
Indeed, much is left to discover concerning the molecular foundation of UBQLN2 
LLPS. Questions remain as to how UBQLN2 facilitates interactions to drive its phase 





behavior. Specifically, how mutated UBQLN2 behaves in vivo is of specific interest due 
to its link to human disease. Current and future studies in our lab aim to introduce 
disease-linked mutations into cells to understand how this may alter its phase-
separating properties. Disease-linked mutations studied here (Chapter 2), P497H and 
P497S are of particular interest as they visibly aggregated in turbidity assays using the 
450C C-terminal construct (Chapter 2, Figure 2). Similarly, disease-linked mutation 
P497L showed significantly slower droplet fusion rates compared to WT, characterizing 
it as an additional mutation of interest. These in vitro experiments suggest that disease-
linked mutations could perturb phase behavior in vivo. Experiments to study these 
mutations would include live cell imaging and analysis of the dynamics of fluorescently 
tagged proteins. Understanding how these mutations may alter UBQLN2 recruitment 
into stress granules, change MLO dynamics and material properties, impair protein 
quality control (PQC) mechanisms, or promote liquid-to-solid transitions would be 
beneficial to elucidate disease mechanisms and to the phase-separating community as 
a whole.  
 As UBQLN2 shares sequential similarity with its homologs UBQLN1, and -4, 
analysis of these proteins would also be an interesting avenue to further elucidate the 
mechanisms behind UBQLN phase separation. UBQLN2 is 74% identical to UBQLN2,  
and UBQLN1 is 60% identical with UBQLN4. Ubiquilin proteins share a high degree of 
homology due to their common major domains (UBL, UBA, STI1-I, STI1-II), with the 
exception of the PXX domain, which is unique to UBQLN2. The Ubiquilin family of 
proteins functionally links the ubiquitination machinery with the proteasome and other 





UBQLN homologs, we can better understand the role of LLPS for the ubiquilin family as 
a whole. Additionally, by comparing and contrasting LLPS behavior between ubiquilin 
homologs, we may begin to elucidate how molecular variances across homologs alter 
their phase behavior. 
 With the role of UBQLN2 in protein quality control (PQC), it is equally important 
to direct future studies to understanding how LLPS partakes in this function. For 
instance, investigation of how disease-linked mutations may alter UBQLN2 engagement 
with PQC machinery could inform the field on potential pathomechanisms. UBQLN2 
proteasomal shuttle functionality could be monitored by its association with proteasomal 
receptors Rpn10 and Rpn13, and ubiquitin (Ub) (Chen et al, 2016). Previous studies 
have suggested that UBQLN1 prefers association with K63-linked polyUb chains over 
K48 polyUb chains. Therefore, studies on full-length and mutated UBQLN2 are 
warranted to determine Ub binding preference and how this binding disrupts or 
modulates UBQLN2 LLPS. As mentioned in Chapter 3, UBQLN2 has a multitude of 
binding partners involved in PQC. Prospective studies characterizing UBQLN2 
association with binding partners has the potential to further inform us on the role of 
UBQLN2 in PQC, and how disease may result in dysfunction of this system.  
 Generation of post-translationally modified UBQLN2 permits us to adopt many 
experimental directions—both in vivo and in vitro. As a starting point, analyses similar to 
those presented in this work would give insight to modified UBQLN2 phase-separating 
properties. Turbidity assays and phase diagram construction can inform about the 
protein’s ability to phase separate under specific conditions. Importantly, size exclusion 





propensity of UBQLN2. Microscopy and NMR experiments would add additional 
information about the proteins’ droplet dynamics, and structure, respectively.  
 Analysis of modified UBQLN2 via expression in eukaryotic Sf9 cells will direct 
future in-cell investigation on the role of post-translational modification (PTM) in 
UBQLN2 LLPS. Molecular weight analysis via mass spectrometry should reveal if, and 
what kind of modification was made to UBQLN2. With this information, we can then 
direct our in-cell experiments to study this specific modification. For example, if 
UBQLN2 is acetylated, we could fluorescently tag acetylated UBQLN2 with an antibody 
specific to acetylated UBQLN2. We could then utilize immunohistochemistry and 
immunoblots to identify where and when UBQLN2 is acetylated, and investigate the 
resulting phase-separating properties. As PTMs are recognized as a major regulatory 
mechanism of liquid-liquid phase-separated puncta in cells, elucidating where and when 
UBQLN2 is modified would provide insight on the regulatory role of PTMs on UBQLN2 
LLPS. Similarly, such experiments could be done with hyperphosphorylation, and 
ubiquitination.  
 Certainly, there are a multitude of avenues to which this work can be applied and 
extrapolated. The work provided herein can be applied not just to fields investigating 
liquid-liquid phase separation, but also to fields studying thermodynamic polymers, 
disease mechanisms, and protein quality control. Overall, these data provide a solid 
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ABSTRACT: UBQLN2 450−624 oligomerizes and under-
goes temperature-responsive liquid−liquid phase transitions
following a closed-loop temperature−concentration phase
diagram. We recently showed that disease-linked mutations to
UBQLN2 450−624 impart highly varying effects to its phase
behavior, ranging from little change to significant decrease of
saturation concentration and formation of gels and aggregates.
However, how single mutations lead to these properties is
unknown. Here, we use UBQLN2 450−624 as a model
system to study the sequence determinants of phase
separation. We hypothesized that UBQLN2 450−624 regions
previously identified to promote its oligomerization are the “stickers” that drive interchain interactions and phase separation.
We systematically investigated how phase behavior is affected by all 19 possible single amino acid substitutions at three sticker
and two “spacer” (sequences separating stickers) positions. Overall, substitutions to stickers, but not spacers, substantially
altered the shape of the phase diagram. Within the sticker regions, increasing hydrophobicity decreased saturation
concentrations at low temperatures and enhanced oligomerization propensity and viscoelasticity of the dense phase. Conversely,
substitutions to acidic residues at all positions greatly increased saturation concentrations. Our data demonstrate that single
amino acid substitutions follow a molecular code to tune phase transition behavior of biopolymers.
■ INTRODUCTION
Liquid−Liquid phase separation (LLPS) is a process by which
a solution of macromolecules demixes into a species-rich liquid
dense phase in equilibrium with a species-poor dilute phase.
LLPS is hypothesized to underlie the assembly of biomolecular
condensates essential for various cellular processes.1,2 In phase-
separating proteins, a major characteristic is multivalency, the
existence of multiple associative motifs of intrinsically
disordered segments or structured domains that form intra-
and interchain interactions.3−5 Accumulating evidence shows
that phase transition behavior is encoded in the amino acid
sequence.6−8 Mutations can tune the conditions necessary for
LLPS, as well as the material properties of these condensates in
vitro and in vivo.9,10 Indeed, dysregulation of condensate
dynamics, assembly, and/or disassembly is linked to diseases,
including amyotrophic lateral sclerosis (ALS) among others.
Therefore, deciphering the molecular code that drives phase
transitions of biopolymers is key to understanding diseases, as
well as designing stimuli-responsive polymers with emergent
properties.
The “stickers” and “spacers” framework is emerging as useful
language to describe the physical origins of LLPS behavior in
proteins. Stickers are the associative motifs that drive LLPS,
whereas the spacers connect the sticker regions and tune LLPS
behavior as well as impart flexibility.11−13 The chemical basis
of sticker interactions that govern phase transition behavior
varies across phase-separating systems. For instance, Arg and
Tyr residues in the FUS family of proteins use cation−π and
π−π stacking interactions to drive LLPS.8 The hydrophobic
effect modulates LLPS of elastin and elastin-like proteins and
other proteins such as Pab1.14−16 Aromatic residues are
essential for mediating TDP-43 LLPS.17 Electrostatic inter-
actions formed via clusters of either positively or negatively
charged residues stabilize Ddx4 protein droplets.18 These
experimental data must be combined to deduce the molecular
grammar underpinning LLPS at physiological conditions for
biological systems. Indeed, π−π contact propensity can be
used to predict LLPS based solely on amino acid sequence.19
Evaluating the effects of amino acid substitutions on phase
transition behavior requires elucidation of full phase diagrams
that map the conditions where the solution phase separates
into protein-dilute and protein-dense phases. For some
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systems, the protein-dense phase also intersects a liquid−gel
phase boundary, where the dense phase undergoes gelation, a
transition from liquid droplets to a noncovalent physically
cross-linked network of molecules.11 The equilibrium protein
concentrations in the protein-dilute and protein-dense phases
are described by the binodal or coexistence curve comprising
both low and high concentration arms. The low concentration
arm defines the protein saturation concentration (cs), below
which the system will be mixed and homogeneous, and above
which, the system will form a distinct second phase such as
protein-dense liquid droplets.20−22 Coexistence curves are
determined by the free energy of the system thereby including
entropy of mixing, as well as the enthalpies of protein−protein,
protein−solvent, and solvent−solvent interactions. The com-
plex interplay of these terms provides the thermodynamic basis
for LLPS in biological systems. Obtaining experimental phase
diagrams and predicting these via computational modeling
and/or simulation are ideal metrics to determine the molecular
driving forces of phase separation and phase separation-driven
gelation.11,23 Therefore, experimental systems are needed to
address this goal, as emphasized in recent literature.22,24
We established a model biopolymer system, the C-terminal
construct of UBQLN2 (450−624), to which we could
experimentally map the effects of single amino acid
substitutions on phase transition behavior. We recently
demonstrated that UBQLN2, a proteasomal shuttle factor
involved in cellular protein quality control mechanisms, phase
separates under physiological conditions, and that UBQLN2
450−624 generally mimics the LLPS behavior of full-length
UBQLN2.25 Furthermore, UBQLN2 450−624 can be easily
expressed and purified from bacteria, enabling the establish-
ment of a large mutagenesis library to study the sequence
effects on phase transitions. We previously identified regions of
UBQLN2 450−624 important for oligomerization and
hypothesized that these same segments are the stickers that
drive LLPS. To test this hypothesis, we systematically
substituted each of the natural amino acids into three sticker
and two spacer positions and obtained low-concentration arms
of temperature−concentration phase diagrams. In agreement
with the stickers and spacers framework, only sticker
substitutions substantially altered the shape of temperature−
concentration phase diagrams, whereas spacer substitutions
only marginally affected coexistence curves. Increasing hydro-
phobicity of the amino acid substitution shifted coexistence
curves such that UBQLN2 phase separated at lower temper-
atures and concentrations. Our data illustrate that single amino
acid substitutions at designated positions in the amino acid
sequence of a protein substantially modify phase transition
behavior of biopolymers. These data can be used to benchmark
analytical and computational models of phase transitions.
■ METHODS
Subcloning, Protein Expression, and Purification.
UBQLN2 mutants were generated from UBQLN2 450−624
using Phusion Site-Directed Mutagenesis Kit (Thermo
Scientific). A tryptophan codon was added to the C-terminal
end of all constructs to facilitate determination of protein
concentration (Figure S1A). UBQLN2 450−624 and all the
mutants were expressed and purified as described by Dao et al,
2018.25 Briefly, the constructs were expressed in Escherichia coli
Rosetta 2 (DE3) pLysS cells in Luria−Bertani (LB) broth at
37 °C overnight. Bacteria were pelleted, frozen, lysed, then
purified via a “salting out” process. NaCl was added to the
cleared lysate to the final concentration of 0.5−1 M. UBQLN2
droplets were pelleted and then resuspended in 6 M urea, 20
mM sodium phosphate, 0.5 mM ethylenediaminetetraacetic
acid (EDTA), 0.1 mM tris(2-carboxyethyl)phosphine (TCEP),
0.02% NaN3 (pH 6.8). Leftover NaCl and urea were removed
through HiTrap desalting column (GE Healthcare). All the
cysteine mutants were subjected to size exclusion chromatog-
raphy (SEC) over a Superdex 75 HiLoad 16/600 column (GE
Healthcare) or an ENrich SEC 650 10 × 300 column (Biorad)
to remove dimer contaminations. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) gels were
performed to confirm the purity of the proteins (Figure S2A).
The identity and molecular weight of each mutant was verified
using electrospray mass spectrometry in positive mode on a
Shimadzu 8040 MS (Figure S2B). Purified proteins were
frozen at −80 °C.
Spectrophotometric Absorbance/Turbidity Measure-
ments. Protein samples were prepared by adding protein
(from stock to a final concentration of 50 μM unless otherwise
noted) to cold sodium phosphate buffer (pH 6.8, 20 mM
NaPhosphate, 0.5 mM EDTA, 0.1 mM TCEP, 0.02% NaN3)
containing 200 mM NaCl and were kept on ice for at least 5
min before the assay. Absorbance at 600 nm was recorded as a
function of temperature by a Beckman DU-640 UV/vis
spectrophotometer using a temperature ramp rate of 2 °C/
min increasing from 16 to 60 °C and then ramped down to 16
°C. Net absorbance values were recorded after subtracting the
absorbance value of a buffer control. Results were averaged
from data collected using proteins from at least two separate
preps and four trials for each (total n ≥ 8) (Figure S2C). Data
were plotted using Mathematica (Wolfram Research).
Phase Diagram Measurements. For the lower critical
solution temperature (LCST) phase transition, that is,
mapping the phase boundary as temperature is increased,
protein samples were prepared as described for the turbidity
measurements. For the upper critical solution temperature
(UCST) arm, protein samples were prepared by mixing
protein and buffer/salt solutions that were incubated at 63 °C
for at least 10 min. Absorbance at 600 nm was recorded as a
function of temperature by a Beckman DU-640 UV/vis
spectrophotometer using a temperature ramp rate of 2 °C/
min decreasing from 60 to 16 °C. Two trials (n = 2) were
conducted using four to five different concentrations of wild-
type (WT) and mutant UBQLN2 450−624 proteins for each
arm. The protein concentrations were chosen to cover as wide
a range as possible to allow observation of phase separation
during the temperature ramps but not at the starting
temperatures (16 and 60 °C for LCST and UCST arms,
respectively). Cloud-point temperatures were determined by









Cloud-point temperatures used were the points of inflection
(c). Cloud-point temperatures were then used to define the
coexistence curve as a function of protein concentration. The
temperature ramp rate was either 1 or 2 °C/min, whichever
yielded the most reproducible, consistent turbidity profiles and
phase diagrams. Specifically, a 1 °C/min ramp rate was used
for the LCST arms of hydrophobic and aromatic substitutions.
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Fitting and plotting of data were done with Kaleidagraph
(Synergy Software).
Bright-Field Imaging of Phase Separation. UBQLN2
450−624 constructs were prepared to contain 100 μM protein
in 20 mM NaPhosphate, 200 mM NaCl, 0.1 mM TCEP, and
0.5 mM EDTA (pH 6.8). Samples were added to MatTek
glass-bottom dishes that had been coated with 5% bovine
serum albumin (BSA), to minimize changes as a result of
surface interactions, and incubated at 37 °C. Phase separation
was imaged on an ONI Nanoimager (Oxford Nanoimaging
Ltd.) equipped with a Hamamatsu sCMOS ORCA flash 4.0 V3
camera using an Olympus 100 × /1.4 N.A. objective. Images
were prepared using Fiji26 and FigureJ plugin.27
Droplet Fusion Assays. UBQLN2 450−624 constructs
were prepared to contain 100 μM protein in 20 mM
NaPhosphate and 0.5 mM EDTA (pH 6.8), except for
P506W at 25 μM protein and P506E and V538E at 300 μM
protein. Samples were added to MatTek glass-bottom dishes
that had been incubated with 5% BSA (to minimize changes as
a result of surface interactions) and incubated at 37 °C. Phase
separation was initiated with the addition of NaCl to a final
concentration of 200 mM. After 10 min of incubation, droplet
formation was imaged as time-lapsed sequences for 3 min on
an ONI Nanoimager equipped with a Hamamatsu sCMOS
ORCA flash 4.0 V3 camera using an Olympus 100 × /1.4 N.A.
objective. Five trials were performed for each mutant. Droplets
chosen for analysis were of similar size and ranged between 2
and 4 μm, except for V538E (8 μm) and P506E (5 μm). For
each mutant, eight fusion events were chosen for analysis and
saved as separate TIFF images including frames from the initial
fusion event.
Relaxation times (time it takes for two fusing droplets to
return to a round shape) were determined by manually
measuring the major axis (a) and the minor axis (b) in pixels
using Fiji software26 and calculating the aspect ratio as α = a/b.
We monitored the fusion events in this way, until the droplets
reached their most relaxed state, or until the aspect ratio was
approximately equal to 1. The aspect ratio for each fusion
event was fit to an exponential decay curve in Matlab
(Mathworks).
α= +τ−y c( )e x0 / (2)
where α0 is the initial aspect ratio, x is time, and τ gives the
characteristic relaxation time.
Size Exclusion Chromatography. Purified UBQLN2
constructs at different concentrations (10, 100, and 500 μM)
were subjected to chromatography over an ENrich SEC 650 10
Figure 1. Turbidity assay screens for mutants in sticker and spacer regions of UBQLN2 450−624. (A) Domain architecture of UBQLN2 450−624
with STI1-II, PXX, and UBA domains colored as cyan, magenta, and green, respectively. Highlighted in yellow are regions identified by NMR to
promote UBQLN2 oligomerization and hypothesized to be stickers.25 Red and blue labels represent sticker and spacer positions studied here,
respectively. Immediately below marks the location of ionizable residues and their expected charge state at pH 7. All of the arginines and most of
the negatively charged residues reside in the folded UBA domain. (B) Fraction of the different types of amino acids in UBQLN2 450−624, which is
high in hydrophobic, polar, glycine, and proline and depleted of aromatic and charged residues. Pie chart follows the general organization in Ruff et
al. 2018.22 (C) Results from spectrophotometric turbidity assay as a function of temperature comparing LLPS of different UBQLN2 mutants using
50 μM protein in 20 mM NaPhosphate and 200 mM NaCl (pH 6.8). The blue asterisks represent WT UBQLN2 turbidity profile for each position.
The red asterisks represent mutants that form unevenly distributed aggregates at one point during the assay. P497H, S, N, and Q formed aggregates
early in the experiment, whereas P506N and Q aggregated at temperatures above 44 °C. Turbidity profiles of amino acid substitutions at each
position are separated by amino acid type: aromatic, hydrophobic, basic, polar, and acidic. Hypothesized stickers and spacers are color-coded red
and blue, respectively, at the top.
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× 300 column (Biorad) on a Biorad NGC FPLC system.
Experiments were conducted using 250 μL of protein at
ambient temperature using 1 mL/min flow rate in pH 6.8
buffer containing 20 mM NaPhosphate, 0.5 mM EDTA, and
0.1 mM TCEP with no added NaCl.
■ RESULTS
Library Generation of UBQLN2 Mutants. We previously
characterized the LLPS properties of full-length UBQLN2 and
several deletion constructs, including UBQLN2 450−624.25
We showed that UBQLN2 oligomerization is a prerequisite for
UBQLN2’s ability to phase separate in vivo and in vitro, as
expected and observed for many other LLPS systems. For
detailed biophysical analyses, we focused on UBQLN2 450−
624 (Figure S1A), whose small size (∼175 amino acids)
enabled the use of nuclear magnetic resonance (NMR)
spectroscopy to monitor backbone amide chemical shifts as a
function of protein concentration on a residue-by-residue basis.
We observed concentration-dependent chemical shifts for
residues 450−509, 555−570, 592−596, and 615−620,
indicating that these residues are involved in UBQLN2
oligomerization (Figures 1A and S1A,B). Here, we hypothe-
sized that the residues in these segments comprise the sticker
regions that drive UBQLN2 phase separation. The amino acid
compositions of these sticker regions and of UBQLN2 450−
624 are hydrophobic and polar (Figures 1B and S1A,C),
consistent with other polymers that phase separate as
temperatures increase such as elastin-like polypeptides
(ELPs).15
We recently showed that ALS-linked mutations P497H,
P497L, P497S, P506A, P506S, and P506T, but not P525S,
significantly altered UBQLN2 450−624 LLPS properties.43
Interestingly, on the basis of our NMR data, residues P497 and
P506 are in a sticker region, and P525 is in a spacer region. We
hypothesized that mutations in the sticker regions would
greatly affect both the dense and dilute phases (e.g., saturation
concentrations, droplet morphology, droplet fusion kinetics),
whereas mutations in the spacer regions would not. To test this
hypothesis, we sought to determine the effects of amino acid
substitutions at these three positions as well as at an additional
sticker position, V564, and spacer position, V538, in the
UBQLN2 450−624 background, hereafter referred to as
UBQLN2 (Figure 1A). All five positions reside in the
intrinsically disordered segment between residues 450 and
580.25 We generated all 19 possible amino acid substitutions at
each of these positions for a total of 95 mutant constructs. We
expressed and purified wild-type and mutant UBQLN2
proteins from E. coli. As done previously, we used salt-induced
phase separation and centrifugation to separate UBQLN2 from
the rest of the E. coli lysates and then desalted into non-phase
separating pH 6.8 buffer containing 20 mM NaPhosphate.
Proteins were more than 95% pure (Figure S2A).
Turbidity Assays Screened for Effects of Amino Acid
Substitutions on LLPS. To systematically screen for the
effects of UBQLN2 mutations on LLPS, we monitored the
change of A600 values between 16 and 60 °C of samples
containing a fixed protein concentration and buffer composi-
tion (see Methods). Previous work from our lab showed that
high and low A600 values correlate with UBQLN2 droplet
formation and droplet clearance, respectively.25 To ensure
reproducibility, we repeated these assays a minimum of eight
times using at least two purified protein stocks (Figure S2C).
Wild-type UBQLN2 undergoes two temperature-responsive
phase transitions (Figure 1C). First, UBQLN2 phase separates
as temperature is increased between 16 and 45 °C. This phase
transition has an LCST, below which the protein solution is
always mixed, regardless of protein concentration. Second, a
solution of phase-separated UBQLN2 becomes less turbid as
temperature is increased between 45 and 60 °C. This second
phase transition has a UCST, above which the protein solution
is always mixed. Together, these data are indicative of phase
behavior following a UCST + LCST closed-loop phase
diagram (Figure 2A).22 Turbidity was generally reversible
when temperature was decreased from 60 to 16 °C (Figure
S2D). These results are consistent with our prior work.43
Focusing first on the overall turbidity assay trends across all
positions, we immediately noticed that mutations in sticker
positions 497, 506, and 564 substantially impacted the
temperature ranges where phase separation was observed, as
compared to mutations in spacer positions 525 and 538. There
is considerable variation in the extent of phase separation
among the different amino acid substitutions in the sticker
positions. It is important to note that, for positions 497, 506,
and 525, the wild-type amino acid is proline, whereas for
positions 538 and 564, it is valine. Regardless of the wild-type
amino acid, the trends for spacer positions 525 and 538 were
nearly identical. In contrast, the overall extent of phase
separation for the sticker substitution at position 564 was
greatly reduced compared to positions 497 and 506. The
turbidity data across the five positions were consistent with our
initial hypothesis that residues 497, 506, and 564 are stickers,
whereas residues 525 and 538 are spacers (Figure 1C).
Second, we organized our turbidity assay results by amino
acid type: hydrophobic (A, G, I, L, M, P, V), aromatic (F, W,
Y), basic (H, K, R), acidic (D, E), and polar (C, N, Q, S, T).
We note the difficulties in assigning amino acids to these
classes, particularly G and P, due to their roles in modulating
protein flexibility and solubility.28 We presented our amino
acid substitutions in terms of decreasing hydrophobicity,
largely following the experimental hydrophobicity scale
determined by Urry et al., 1992.29 Among the sticker positions
497, 506, and 564, increased hydrophobicity promoted
UBQLN2 LLPS and lowered the temperature threshold for
phase separation. Aromatic substitutions at the sticker
positions decreased the temperatures when phase separation
was first observed, in many cases below 16 °C, the starting
temperature of the experiment. Notably, the effects on the
mutations on the turbidity profiles varied by position even
among stickers. For example, UBQLN2 mutants with Ile or
Phe substitutions at position 506 remained turbid for the entire
temperature range (16−60 °C), whereas phase-separating
solutions of P497F and P497I began clarifying at 40 °C. These
observations illustrated that Ile and Phe substitutions to both
P497 and P506 impact LCST and UCST phase transitions but
via different mechanisms. Of the 95 mutants, only six visibly
aggregated during the turbidity assay experiments: P497H,
P497S, P497N, P497Q, P506N, and P506Q (Figure S2E). Of
these, two are disease-linked mutations (P497H and P497S).
Although the effects of the spacer mutations on LLPS were
much less drastic compared to those in the sticker positions,
we still observed large increases in the absolute intensity of the
absorbance signal, especially among substitutions to aromatic
and more hydrophobic residues. It is possible that these
substitutions made the spacer positions more sticker-like,
hence increasing the degree of phase separation of the solution.
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Morever, the turbidity assay does not directly measure the
number of droplets but the scattering of the samples.
Scattering is highly dependent on differences in the size of
the droplets, which might change as the result of the
substitutions. One notable similarity between stickers and
spacers was the effect of Asp and Glu substitutions, both of
which significantly disrupted phase separation at all positions
tested. Together, these data emphasize that perturbations to
LLPS properties of proteins are very sensitive to both the type
of amino acid substitution and the position in the amino acid
sequence.
Effects of Amino Acid Substitutions on Phase
Diagrams. To quantitatively compare the effects of single
amino acid substitutions on phase transitions of UBQLN2 and
determine the driving forces for UBQLN2 phase separation,
we experimentally obtained temperature−concentration phase
diagrams for the 19 substitutions at two representative
positions: a sticker residue (P506) and a spacer residue
(V538) (Figure 2). At a protein concentration for which no
LLPS was observed at the start of the experiment, we
performed temperature-ramping turbidity assays and deter-
mined Tcp(infl), the cloud-point temperature at the inflection
point of the transition (Figure S3).30 There are other methods
to characterize the conditions when phase transitions occur,
including using microscopy to monitor onset or applying a
threshold to changes in absorbance-temperature curves. For
practical reasons, we chose the inflection point, Tcp(infl), for
comparison across different protein samples. The experimental
Tcp values at different protein concentrations were used to map
the coexistence curves (Figure 2). Since UBQLN2 exhibits
both LCST and UCST phase transition behavior, Tcp
associated with the LCST transition was determined by
increasing temperature from 16 to 60 °C, whereas Tcp values
associated with the UCST transition were determined by
starting turbidity assay experiments at 60 °C and ramping
down to 16 °C (see Methods). We tried these experiments at
low (μM) as well as high (up to 3 mM) protein
concentrations. However, the protein solutions were always
cloudy or contained aggregates at the higher concentration
ranges at the start of the experiments (both 16 and 60 °C).
Therefore, we focused on obtaining the low-concentration arm
(cs) of the coexistence curves (Figure 2A). As expected from
the turbidity assays (Figure 1C), the experimental phase
diagram for WT UBQLN2 resembles that of a UCST-LCST
closed-loop phase diagram, indicating two temperature-
responsive phase transitions between 16 and 60 °C (Figure
2B).
Strikingly, amino acid substitutions at sticker position 506
not only shifted the position of the coexistence curves but also
changed the overall shape of the phase diagram (Figure 2B).
Meanwhile, amino acid substitutions at spacer position 538
Figure 2. Temperature−Concentration phase diagrams for represen-
tative sticker and spacer residues in UBQLN2. (A) Schematic of a
closed-loop phase diagram showing both UCST and LCST behaviors.
The black dots represent the experimental data points for the low
concentration arm obtained in this study to partially map the phase
diagram. (B) Effects of amino acid substitutions in the sticker (pink,
P506) region and in the spacer (cyan, V538) region compared to WT
UBQLN2 (black). Circled in black are D and E mutants for each
Figure 2. continued
position. (C) Effects of amino acid substitutions separated by amino
acid type: aromatic (F, W, Y), hydrophobic (A, G, I, L, M, P, V), basic
(H, K, R), polar (C, N, Q, S, T), and acidic (D, E). The dashed lines
are guides that connect the UCST phase transition cloud-point
temperatures to the LCST ones. Both arms of P506N and the UCST
arm of P506Q are missing due to formation of aggregates during the
assays. The UCST arms for V538W, V538Y, V538R, V538K, P506D,
and P506E are missing, since we observed either no turbidity or
nonzero turbidity values at 60 °C at all concentrations tested.
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only mildly shifted coexistence curves but generally displayed a
phase diagram with similar shape to that of WT. In other
words, mutations at position 538 minimally perturbed the cs
needed for LLPS. These observations are entirely consistent
with the expected behaviors of stickers and spacers.8,20 The
major exceptions to these observations were acidic amino acid
substitutions, for which the cs values of the dilute phase were
greatly increased for all positions (see below).
Among the classes of amino acid substitutions, aromatic and
hydrophobic amino acid mutations at sticker position 506
substantially affected the phase diagram of UBQLN2.
Furthermore, increasing hydrophobicity of the amino acid
substitution correlated with decreasing cs values of the LCST
phase transition. The coexistence curves all shifted to the left as
hydrophobicity of the amino acid substitution increased. These
data are completely consistent with our prior work that showed
lowered cs of UBQLN2 for hydrophobic disease-linked
mutations T487I and P497L.43 Together, the data suggest
the importance of the hydrophobic amino acids in driving
UBQLN2 phase separation. Indeed, many of the amino acids
in sticker regions are hydrophobic, as we previously
characterized (Figure S1A).25
At position 506, aromatic substitutions substantially changed
the shape of UBQLN2’s phase diagram, but differently
depending on the amino acid. Tyr and Trp mutations shifted
the UCST arm of the phase diagram downward compared to
WT, with UCST cloud-point temperatures below 50 °C at
least up to 200 μM protein concentrations. On the one hand,
the Phe substitution was always phase separated over the entire
temperature range tested, except at low protein concentrations
(<20 μM). In contrast, the Phe substitution at position 538
minimally impacted the overall shape of the phase diagram,
while all aromatic substitutions at this position imposed a
leftward shift of the coexistence curves to lower protein
concentrations. Notably, we could not obtain V538 Tyr and
Trp UCST phase transition cloud points, since we could not
establish clear baselines at 60 °C for any protein concen-
trations that exhibited turbidity during the temperature
ramping assays. Therefore, these cloud-point values are likely
to be greater than 60 °C. We speculate that the aromatic
substitutions impart stickerlike properties to position 538, thus
decreasing the cs values for LLPS. It is apparent that π-stacking
interactions involving aromatic amino acids promote LLPS in
other systems, such as FUS and TDP-43.8,17
Polar substitutions at the sticker but not spacer position
affected the phase diagram of UBQLN2. This makes sense
given the polar amino acid composition (Figure 1B). At
position 506, both LCST and UCST transitions were
perturbed. Interestingly, the LCST transitions of Ser, Thr,
and Gln substitutions nearly superimposed, while the UCST
arm of the coexistence curves decreased in the order C > S >
T. We also noted that five of the six substitutions that
produced aggregates (Figure S2E) were polar substitutions:
P497S, P497Q, P497N, P506Q, P506N.
Basic amino acid substitutions shifted coexistence curves to
the left, with little difference among the three basic amino acids
(His, Lys, Arg). The effects were more substantial for the
sticker position than for the spacer. Interestingly, acidic amino
acid substitutions had the opposite effects and greatly
increased the saturation concentrations needed for UBQLN2
LLPS, as well as narrowing the temperature region where the
protein phase-separated. We speculate that these effects can be
partially explained by the bulkiness of the side-chain
substitution (for Arg and Lys, whose side chains have some
hydrophobic character) as well as the charge state of the
UBQLN2 construct. At 25 °C, the predicted pI or isoelectric
point of the UBQLN2 450−624 construct is ∼4.4, with less
than 7% of the protein containing ionizable residues (Figure
1B). This means that the protein is negatively charged at pH
6.8, the pH chosen for our experiments. Introduction of
positive charges provides attractive Coulombic interactions
between the substitution and the overall charge of the protein,
thereby promoting intermolecular interactions between
UBQLN2 molecules to drive phase separation. In contrast,
acidic substitutions may do the opposite, potentially providing
repulsive interactions between UBQLN2 molecules and
decreasing phase separation.
Hydrophobic Sticker but Not Spacer Substitutions
Altered Droplet Morphology and Increased Viscoelastic
Properties. Mapping the lower concentration arms of the
phase diagram allowed us to evaluate the effects of the
substitutions on the dilute phase. However, what are the
consequences of the substitutions on the dense phase? To
answer this, we first used brightfield microscopy to investigate
the morphology of UBQLN2 droplets of representative amino
acid substitutions from the different classes of residues,
including W (aromatic), G and L (hydrophobic), R (basic),
Q (polar), and E (acidic) across the five positions studied here
(Figure 3A). In general, the droplet morphologies at these
different positions correlated well with the turbidity assay
results. Mutants exhibiting similar turbidity profiles as WT
UBQLN2 (e.g., P525 and V538 mutants) produced spherical
droplets of similar size as WT. Mutants that exhibited
significantly enhanced turbidity (P497W, P497L, P506W,
P506L) also formed amorphous droplets (Figures 1C and 3A).
Microscopy also confirmed the existence of aggregates as
observed in the turbidity assays for P497Q (P506Q aggregates
were observed at temperatures higher than 37 °C during the
turbidity assays and therefore were not seen under the
microscope). Surprisingly, acidic substitution E, which showed
little or no turbidity at the condition tested, appeared to form
small aggregate-like species at all five positions at our
experimental conditions. Over time, these aggregate-like
species sometimes morphed into droplets as observed for
V538E (Figure 3A). Consistent with our hypothesis, mutations
at spacer positions 525 and 538 (except V525R, P525E, and
V538E) had minimal effects on the morphology of the
droplets, while mutations at sticker positions 497, 506, and 564
elicited different morphologies ranging from round like WT-
like to amorphous droplets and/or aggregates.
To describe the effects of amino acid substitutions on the
properties of the dense phase quantitatively, we analyzed
droplet fusion kinetics. We noticed that, for many
substitutions, two fusing droplets relaxed into spherical shapes
within seconds, while for other substitutions, spherical shapes
were not achieved within a 3 min experimental window
(Figure 3B). Since the sphericity of droplets stems from
surface tension, the rates of droplet fusion report on droplet
viscosity and surface tension.31 To assess the liquidity of
mutant UBQLN2 droplets, we measured the time it took for
two fusing droplets to return to a spherical shape (or round in
two dimensions). We extracted relaxation times from droplet
fusion measurements for seven amino acid substitutions at the
sticker and spacer positions, 506 and 538, respectively, of
protein samples that had been incubated in phase-separating
conditions for 10 min (Figure 3B,C). Remarkably, droplets for
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V538 mutants fused quickly and with similar relaxation times
as that for WT UBQLN2, despite the markedly different types
of amino acid substitutions tested. These observations are fully
consistent with the spacer characteristics expected for position
538, in that spacer amino acid substitutions minimally
perturbed phase separation properties. In contrast, the type
of amino acid substitution at sticker position 506 had a
substantial impact on the rate of droplet relaxation. Bulky
aromatic and hydrophobic substitutions resulted in signifi-
cantly slowed droplet relaxation events, but not for polar and
ionizable substitutions. These data suggest that hydrophobic
and aromatic amino acids promote UBQLN2 intermolecular
interactions that increase viscoelasticity of UBQLN2 droplets
as well as drive UBQLN2 phase separation (see below).
Hydrophobic and Aromatic Sticker Substitutions
Increase UBQLN2 Oligomerization. As UBQLN2 oligome-
rization is a prerequisite for phase separation,25 we probed
UBQLN2 self-association propensity using SEC under non-
phase separating conditions (i.e., 20 mM NaPhosphate without
added NaCl). We previously demonstrated that WT UBQLN2
is monomeric at low protein concentrations (up to ∼100 μM)
but forms higher-order oligomers at higher concentrations
(∼500 μM).25 Indeed, SEC peak elution volumes for WT
decreased as protein concentration increased between 10 and
500 μM, as expected for UBQLN2 oligomerization. Therefore,
we subjected representative mutants at each position to size
exclusion chromatography using three protein concentrations
(10, 100, 500 μM).
All of the mutants studied exhibited concentration-depend-
ent oligomerization; increasing protein concentrations led to a
decrease in elution volume (Figure 4). Strikingly, almost all of
the spacer mutants (P525 and V538) exhibited a concentration
dependence that followed the pattern of WT UBQLN2. The
only exception was P525E, where a small population of large
particles eluted near the void volume (∼9 mL). Of all the E
mutants, P525E showed the most aggregates by microscopy
(Figure 3A). Among the sticker mutants, four oligomerized
substantially more than WT: P497W, P497L, P506W, and
P506L. Sedimentation velocity analytical ultracentrifugation
experiments showed that hydrophobic mutations T487I and
P497L also produced high-order oligomers.43 V564W and
V564L oligomerized slightly more than WT but not to a
significant extent, since the wild-type amino acid is valine,
which is already hydrophobic. These data suggest that aromatic
and hydrophobic substitutions promote UBQLN2 self-
association and thus drive LLPS at lower protein concen-
trations than WT (Figure 2) and enhance the viscoelasticity of
droplets (Figure 3).
■ DISCUSSION
How amino acid substitutions alter thermoresponsive phase
transition behavior of proteins is critical to elucidating the
driving forces of phase separation. Here, we demonstrated that
both LCST and UCST phase transition behaviors of UBQLN2
can be differentially tuned by single amino acid substitutions.
The observations herein provide evidence that the stickers and
spacers framework is useful to predicting the positions in a
given amino acid sequence that drive phase separation
behavior.8,12,20 Regardless of amino acid type, substitutions
at sticker but not spacer positions elicited major changes to the
overall shape and characteristics of the phase diagram (Figures
2 and 5).
Our original hypothesis considered the stickers of UBQLN2
to be residues that exhibited large concentration-dependent
changes in amide chemical shifts obtained by NMR spectros-
copy.25 In the stickers and spacers framework, the number of
Figure 3. Amino acid substitutions in the sticker, but not spacer,
regions affect droplet properties. (A) Light microscopy of different
UBQLN2 mutants over 10 and 30 min at 37 °C using 100 μM protein
at sticker (P497, P506, V564) and spacer (P525, V538) positions.
Scale bar = 5 μm. (B) Snapshots of droplet fusion over a nine second
window (for WT and V538L and V538W) and a 36 s window (for
P506L and P506W), indicating differences in droplet fusion kinetics
between substitutions at a sticker position (P506) and a spacer
position (V538). Droplets were imaged 10 min after incubating 100
μM protein (except for P506W (25 μM), P506E and V538E (300
μM)) at 37 °C in buffer containing 20 mM NaPhosphate and 200
mM NaCl (pH 6.8). Scale bar = 2 μm. (C) Average characteristic
relaxation times for WT and mutant droplet fusion. Error bars
represent the standard deviation over eight droplets.
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stickers and their “stickiness” control the saturation concen-
trations (cs) and the coexistence curve for LLPS, whereas
spacer residues weakly modulate these parameters. These
expectations are completely in line with our observations on
amino acid substitutions at the three stickers (P497, P506, and
V564) and two spacers (P525, V538) (Figure 1C,B).
Strikingly, not only did single amino acid substitutions alone
substantially shift cs values but the effects of these substitutions
followed particular trends to create a rich molecular code that
governs UBQLN2 LLPS.
Self-association and LLPS of UBQLN2 are mediated by
hydrophobicity involving either aliphatic or aromatic residues
(Figure 2, Figure 4), in line with the hydrophobic composition
of the amino acid sequence (Figure 1B). At position 506,
decreased cs values for the LCST phase transition correlated
with increased hydrophobicity of amino acid substitution
(Figure S5). Indeed, while we did not obtain phase diagrams
for P497 mutants, the LCST transition temperatures for
aromatic and hydrophobic substitutions at P497 followed the
same trend as that at P506 (Figure 1C). LCST phase
transitions require hydrophobicity.22,25,32 UBQLN2 also has
high proline and glycine content (Figure 1B), which is a
frequent component of proteins that undergo LCST phase
transitions, such as Pab1, tropoelastins, and the spindle-
associated BuGZ protein.14,15,33
UBQLN2 exhibits a closed-loop phase diagram with both
LCST and UCST phase transitions, such that the protein
solution is well-mixed either above the UCST or below the
LCST (Figure 2A). The thermodynamics of the underlying
phase transitions can be explained by the entropic and
enthalpic forces experienced by nonpolar particles in water
as a function of temperature.34 At low temperature, solubility
of hydrophobic particles is high, partially due to water
structuring around the hydrophobic groups. As temperature
increases, the entropic cost to organize water also increases to a
point at which solvent molecules are released from
surrounding hydrophobic side chains, promoting demixing
(phase separation) to minimize the free energy of the system.
In polymer solutions, dehydration of hydrophobic groups is
accompanied by attractive polymer−polymer interactions that
also contribute to demixing.35 As temperature increases
further, entropy also increases promoting a UCST transition
where homogeneous mixing of the polymer solution occurs. A
decrease in polymer−polymer and solvent−solvent interac-
tions also promotes mixing.36 This UCST transition is not
always observed, as biopolymers generally denature at high
temperatures, but UBQLN2 450−624 remains well-behaved
up to 60 °C.43
As illustrated in Figure 1B, more than 25% of UBQLN2
450−624 contains polar residues (Q, N, S, T). Therefore, the
Figure 4. Oligomerization propensities of different UBQLN2 mutants. Representative SEC profiles of UBQLN2 mutants at 10 μM (thinnest line),
100 μM (medium-thick), and 500 μM (thickest) protein concentrations. For each mutant, WT SEC curves were plotted in gray for visual
comparison.
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driving forces underlying UBQLN2 phase separation are likely
due to a combination of the hydrophobic effect and polar
interactions. Of note, polymers rich in polar residues (N, Q)
undergo a collapse transition reminiscent of the intrachain
collapse in hydrophobic biopolymers, even though the
underlying forces for polar collapse likely include other
interactions such as intrachain hydrogen bonding and
amide−solvent interactions.28,37 Interestingly, the cs values
for the LCST transition correlated well with the hydro-
phobicity of the amino acid substitution at P506 when all
nonionizable residues were considered (Figure S5B). Polar
substitutions also promoted aggregation (Figure S2E).
The polar groups in UBQLN2 likely modulate the UCST
transition, as favorable polymer−polymer interactions among
polar and/or ionizable tracts in intrinsically disordered proteins
(IDPs) such as FUS and hnRNPA1 are considered drivers of
UCST transitions in biopolymers.6,9 An increase and decrease
in the UCST part of coexistence curves correspond to stronger
and weaker polymer−polymer interactions, respectively.
Complicating matters, hydrophobic groups also modulate
UCST, and the effects of hydrophobic amino acid substitutions
on the UCST transitions in UBQLN2 are certainly complex.
At P506, increased hydrophobicity moderately tracks with
decreased cloud-point temperatures for the UCST transition
(Figure S5A). Our observations are opposite of what was seen
in designed IDP polymers, for which UCST cloud points
increased with increasing hydrophobicity.38 Interestingly, our
turbidity data profile for hydrophobic substitutions at P497 are
in better agreement with Quiroz et al.38 We must acknowledge
that prolines are structure-disrupting amino acids. In addition,
peptide bonds preceding prolines can isomerize between cis
and trans conformations. Therefore, the differences in
observed turbidity profiles for proline substitutions at different
positions could be partially explained by changes to backbone
conformation and flexibility. These observations emphasize the
heterogeneity of the phase transition behavior for the same
type of amino acid substitution even among the sticker
positions.
Remarkably, Asp and Glu mutations at any of the five tested
positions in UBQLN2 reduced phase separation and
significantly compressed the phase-separating regime in the
UBQLN2 phase diagram (Figure 2). Importantly, these acidic
mutations are also phosphomimetic substitutions. These data
highlight the potential impact of post-translational modifica-
tions such as phosphorylation on modulating phase separation
behavior. However, the effect is likely very dependent on the
electrostatics of the protein system involved.8,39
Material properties of the dense phase are also modified by
amino acid substitutions.9,40 The liquid−liquid phase diagram
therefore includes liquid-gel phase boundaries as schematized
in Figure 5.6 Indeed, the stickers and spacers framework is one
formalism that quantitatively addresses gelation.13 We
observed that hydrophobic and aromatic amino acid
substitutions only in sticker position P506 showed significantly
Figure 5. Illustration of effects of UBQLN2 sticker and spacer substitutions on temperature−concentration phase diagrams. (A) Effects of spacer
and different types of sticker substitutions on the shape of the phase diagram. Amino acid substitutions in sticker regions move the location and
shape of the phase boundaries. However, high concentration arms are hypothetical and for illustration purposes only. We hypothesize that the high
concentration arms of some of the sticker mutants also move as we observed changes to the material properties of the dense phase. (B) Effects of
mutations on phase diagrams and viscoelasticity. Gray and yellow shapes represent regions where the dense phase is liquid-like and gel/aggregate-
like, respectively. (left) Green arrow represents a condition where dense phase is liquid. (right) Green arrow represents a condition where dense
phase is solid-like (i.e., gel-like consistency).
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slowed droplet fusion kinetics (Figure 3), and those same
mutants exhibited increased oligomerization propensity
(Figure 4). At least in the UBQLN2 system, material
properties of the dense phase appear linked to the propensity
for UBQLN2 to oligomerize. We also noted that mutations
that increased the propensity of oligomerization promoted
UBQLN2 LLPS and led to slowed droplet fusion kinetics.43
However, this is not always the case, as spacer mutations
significantly slowed droplet fusion kinetics in the FUS family of
proteins,8 and physicochemical properties of spacers in
multidomain proteins modulate the liquid−liquid and
liquid−gel phase boundaries.11
In summary, our work here provides a rich data set to be
used as a benchmark for analytical and computational models
of phase separation. While mean-field theories such as Flory−
Huggins approximate phase separation behavior for several
systems,18,41 sequence-dependent frameworks will be essential
to capture the nuances of phase-separating systems such as
UBQLN2.42 The stickers and spacers framework has already
been used to successfully examine the underlying forces of
phase separation in the FET family of RNA-binding proteins.8
Unraveling the complexities of solvent−solvent, polymer−
polymer, and polymer−solvent interactions will establish the
molecular code of phase-separating systems.
■ CONCLUSIONS
In this work, we put forth UBQLN2 450−624 as a model
system to study the physicochemical molecular determinants
of phase separation. We employed a battery of spectrophoto-
metric, microscopy, and size exclusion chromatography
experiments to systematically elucidate how amino acid
substitutions at different positions in the protein sequence
modulate phase separation. Experimental phase diagrams
revealed that we can describe UBQLN2 as an associative
polymer with stickers and spacers that drive and modulate
phase separation behavior. Single amino-acid substitution can
substantially shift coexistence curves in a residue type-
dependent manner. It is our expectation that our experimental
data can be used to rigorously design and benchmark analytical
models and molecular simulations of phase separation. This
work can be used to elucidate effects of disease-linked
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Carlos A. Castañeda received his Ph.D. from the Program in
Molecular Biophysics at Johns Hopkins University working with Dr.
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